{ "meta": { "tracker_site_url": "https://psilocybin-research.com", "publication_tracker_url": "https://psilocybin-research.com/", "generated_at_utc": "2026-07-05 13:25:06", "record_count": 59 }, "papers": [ { "id": 4178, "title": "Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacin", "normalized_title": "symptom level antidepressant response to psilocybin exploratory outcomes comparing psilocybin treatment to niacin", "authors": "E. Lopez, J O Lundberg, F. Hieronymus, M. Beckman, H. Yngwe, C.J. Ekman, M. Tiger, N. Edvall", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2026.106904", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2026.106904", "keywords": "Medicine, Antidepressant, Niacin, Psilocybin, Pharmacology, Mirtazapine, Internal medicine, Psychiatry, Clinical trial, MEDLINE, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Pain Management and Placebo Effect", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7161898772\",\"openalex_url\":\"https://openalex.org/W7161898772\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5136584767\",\"display_name\":\"E. Lopez\",\"orcid\":null},{\"id\":\"https://openalex.org/A5125067605\",\"display_name\":\"J O Lundberg\",\"orcid\":null},{\"id\":\"https://openalex.org/A5082700012\",\"display_name\":\"F. Hieronymus\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136592297\",\"display_name\":\"M. Beckman\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136572678\",\"display_name\":\"H. Yngwe\",\"orcid\":null},{\"id\":\"https://openalex.org/A5011966942\",\"display_name\":\"C.J. Ekman\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121794244\",\"display_name\":\"M. Tiger\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136580362\",\"display_name\":\"N. Edvall\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2026.106904\",\"is_oa\":true}}", "topic_tags": "Chronic Pain,Pharmacology,Clinical Trial,Toxicity", "study_type": "Clinical Trial", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7161898772" }, { "id": 4177, "title": "Self-reported benefits and harms of microdosing with natural psilocybin: preliminary results from a naturalistic study", "normalized_title": "self reported benefits and harms of microdosing with natural psilocybin preliminary results from a naturalistic study", "authors": "I. Totomanova, E.C.H.M. Haijen, P.P.M. Hurks, NL Mason, JG Ramaekers, K.P.C. Kuypers", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2026.106942", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2026.106942", "keywords": "Natural (archaeology), Psychology, Social psychology, Naturalistic observation, Action (physics), Agency (philosophy), Naturalism, Applied psychology, Environmental health, Behaviour change, Psychedelics and Drug Studies, Paranormal Experiences and Beliefs, Pain Management and Placebo Effect", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7161827243\",\"openalex_url\":\"https://openalex.org/W7161827243\",\"openalex_relevance_score\":4,\"openalex_relevance_reasons\":[\"title:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121833055\",\"display_name\":\"I. Totomanova\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121779284\",\"display_name\":\"E.C.H.M. Haijen\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136595014\",\"display_name\":\"P.P.M. Hurks\",\"orcid\":null},{\"id\":\"https://openalex.org/A5110749453\",\"display_name\":\"NL Mason\",\"orcid\":null},{\"id\":\"https://openalex.org/A5103425123\",\"display_name\":\"JG Ramaekers\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121765730\",\"display_name\":\"K.P.C. Kuypers\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2026.106942\",\"is_oa\":true}}", "topic_tags": "Chronic Pain,Microdosing", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7161827243" }, { "id": 4176, "title": "Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adults", "normalized_title": "dynamic response of intrinsic connectivity networks to low dose psilocybin during face matching in autistic adults", "authors": "Y. Ge, T.P. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, F.M. Ponteduro, N. Khalil, S. Fenn-Moltu, NA Puts, E. Daly, D.G.M. Murphy, G.M. McAlonan, D. Batalle", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2026.106906", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2026.106906", "keywords": "Psilocybin, Psychology, Face (sociological concept), Matching (statistics), Computer science, Neuroscience, Facial recognition system, Artificial intelligence, Cognitive psychology, Face perception, Autism, Functional connectivity, Property (philosophy), Communication, Computer vision, Psychedelics and Drug Studies, Paranormal Experiences and Beliefs, Face Recognition and Perception", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7161826543\",\"openalex_url\":\"https://openalex.org/W7161826543\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5136536811\",\"display_name\":\"Y. Ge\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136531578\",\"display_name\":\"T.P. Whelan\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121797325\",\"display_name\":\"M. Dimitrov\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121799276\",\"display_name\":\"C.L. Ellis\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121833749\",\"display_name\":\"F. Moruzzi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121799145\",\"display_name\":\"J. Kangas\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136563571\",\"display_name\":\"F.M. Ponteduro\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121759661\",\"display_name\":\"N. Khalil\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136536804\",\"display_name\":\"S. Fenn-Moltu\",\"orcid\":null},{\"id\":\"https://openalex.org/A5114081015\",\"display_name\":\"NA Puts\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136522615\",\"display_name\":\"E. Daly\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121832208\",\"display_name\":\"D.G.M. Murphy\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121782292\",\"display_name\":\"G.M. McAlonan\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136507347\",\"display_name\":\"D. Batalle\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2026.106906\",\"is_oa\":true}}", "topic_tags": "General", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7161826543" }, { "id": 4160, "title": "Electrical brain changes following psilocybin administration in sprague-dawley rats", "normalized_title": "electrical brain changes following psilocybin administration in sprague dawley rats", "authors": "B. Richardson, V. Bruno, J. O'Byrne, G. Gobbi", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106819", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.106819", "keywords": "Medicine, Pharmacology, Psilocybin, Central nervous system, Administration (probate law), Drug administration, Anesthesia, Neuroscience, Hallucinogen, Hippocampus, Action (physics), Drug, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7118013054\",\"openalex_url\":\"https://openalex.org/W7118013054\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121759287\",\"display_name\":\"B. Richardson\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121787318\",\"display_name\":\"V. Bruno\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121802428\",\"display_name\":\"J. O'Byrne\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121772763\",\"display_name\":\"G. Gobbi\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106819\",\"is_oa\":true}}", "topic_tags": "Pharmacology,Toxicity", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7118013054" }, { "id": 4159, "title": "Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic people", "normalized_title": "low dose psilocybin differentially alters resting state network connectivity in autistic and non autistic people", "authors": "T. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, N. Khalil, G. Ivin, E. Daly, NA Puts, D.G.M. Murphy, G.M. McAlonan", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105782", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.105782", "keywords": "Neuroscience, Psilocybin, Psychology, Schizophrenia (object-oriented programming), Medicine, Central nervous system, Nerve net, Computer science, Biology, Autism, Functional connectivity, Psychedelics and Drug Studies, Paranormal Experiences and Beliefs, Forensic Toxicology and Drug Analysis", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7118011913\",\"openalex_url\":\"https://openalex.org/W7118011913\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121800389\",\"display_name\":\"T. Whelan\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121797325\",\"display_name\":\"M. Dimitrov\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121799276\",\"display_name\":\"C.L. Ellis\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121833749\",\"display_name\":\"F. Moruzzi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121799145\",\"display_name\":\"J. Kangas\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121759661\",\"display_name\":\"N. Khalil\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121828214\",\"display_name\":\"G. Ivin\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121831468\",\"display_name\":\"E. Daly\",\"orcid\":null},{\"id\":\"https://openalex.org/A5114081015\",\"display_name\":\"NA Puts\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121832208\",\"display_name\":\"D.G.M. Murphy\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121782292\",\"display_name\":\"G.M. McAlonan\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105782\",\"is_oa\":true}}", "topic_tags": "Toxicity", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7118011913" }, { "id": 4158, "title": "Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial", "normalized_title": "efficacy and safety of psilocybin in treatment resistant major depression episode results of a randomized active placebo controlled trial", "authors": "L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105779", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "keywords": "Medicine, Depression (economics), Psilocybin, Randomized controlled trial, Internal medicine, Psychiatry, Major depressive disorder, Clinical trial, Treatment-resistant depression, Adverse effect, Anxiety, Placebo, Placebo response, Psychedelics and Drug Studies, Pain Management and Placebo Effect, Paranormal Experiences and Beliefs", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7118005769\",\"openalex_url\":\"https://openalex.org/W7118005769\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121822190\",\"display_name\":\"L.J. Mertens\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121824543\",\"display_name\":\"M. Koslowski\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121783775\",\"display_name\":\"F. Betzler\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121792507\",\"display_name\":\"M. Brand\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121791537\",\"display_name\":\"R. Evens\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121810759\",\"display_name\":\"L. Krätner\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121833521\",\"display_name\":\"A. Jungaberle\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121791366\",\"display_name\":\"H. Jungaberle\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121773388\",\"display_name\":\"T. Majić\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121822296\",\"display_name\":\"C.N. Schmitz\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121811371\",\"display_name\":\"A. Ströhle\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121789885\",\"display_name\":\"D. Scharf\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121826605\",\"display_name\":\"M. Spangemacher\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121785997\",\"display_name\":\"M. Wolff\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121758999\",\"display_name\":\"Z. Assadi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121789441\",\"display_name\":\"B. Scharif\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121823024\",\"display_name\":\"L. Becher\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121824758\",\"display_name\":\"L.V. Färber\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121806858\",\"display_name\":\"N. Kirchen\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121800185\",\"display_name\":\"E. Kulakova\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121759413\",\"display_name\":\"L. Kunz\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121774631\",\"display_name\":\"A. Meijer\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121756009\",\"display_name\":\"B. Rohrmoser\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121827624\",\"display_name\":\"S. Wellek\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121760402\",\"display_name\":\"M. Berger\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121772024\",\"display_name\":\"G. Gründer\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105779\",\"is_oa\":true}}", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7118005769" }, { "id": 4157, "title": "The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trial", "normalized_title": "the impact of comp360 psilocybin on anhedonia post hoc analyses from a phase iib randomised controlled trial", "authors": "L. Marwood, M. Young, J. Chai-Rees, S. Mistry, S. Maxwell, G.M. Goodwin", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106572", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.106572", "keywords": "Randomized controlled trial, Medicine, Psilocybin, Phase (matter), Pharmacology, Internal medicine, Anesthesia, Clinical trial, Placebo, MEDLINE, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7118005328\",\"openalex_url\":\"https://openalex.org/W7118005328\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"compound:comp360\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121821524\",\"display_name\":\"L. Marwood\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121806415\",\"display_name\":\"M. Young\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121754295\",\"display_name\":\"J. Chai-Rees\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121778088\",\"display_name\":\"S. Mistry\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121801763\",\"display_name\":\"S. Maxwell\",\"orcid\":null},{\"id\":\"https://openalex.org/A5023164918\",\"display_name\":\"G.M. Goodwin\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106572\",\"is_oa\":true}}", "topic_tags": "Pharmacology,Clinical Trial,Randomized Controlled Trial,Toxicity", "study_type": "Randomized Controlled Trial", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7118005328" }, { "id": 4156, "title": "Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration model", "normalized_title": "psilocybin and ibogaine as therapeutic candidates for cocaine addiction insights from a rat self administration model", "authors": "I.R.A. Koutrouli, K. Šíchová, W. Kacper, V. Brejtr, K. Aleksič, N. Miniariková, E. Lhotková, M. Nikolič, T. Páleníček", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106393", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.106393", "keywords": "Psilocybin, Pharmacology, Medicine, Hallucinogen, Chemistry, Neuroscience, Drug, Riluzole, Animal model, Mephedrone, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Neurotransmitter Receptor Influence on Behavior", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7117971173\",\"openalex_url\":\"https://openalex.org/W7117971173\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121823805\",\"display_name\":\"I.R.A. Koutrouli\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121827695\",\"display_name\":\"K. Šíchová\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121813066\",\"display_name\":\"W. Kacper\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121754648\",\"display_name\":\"V. Brejtr\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121784252\",\"display_name\":\"K. Aleksič\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121769225\",\"display_name\":\"N. Miniariková\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121818721\",\"display_name\":\"E. Lhotková\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121752090\",\"display_name\":\"M. Nikolič\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121832941\",\"display_name\":\"T. Páleníček\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106393\",\"is_oa\":true}}", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Animal Study,Toxicity", "study_type": "Animal Study", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7117971173" }, { "id": 4155, "title": "An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes", "normalized_title": "an open label study of single dose comp360 psilocybin for post traumatic stress disorder safety tolerability and secondary efficacy outcomes", "authors": "N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106821", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "keywords": "Medicine, Stress (linguistics), Psilocybin, Internal medicine, Depression (economics), Fight-or-flight response, Clinical trial, Disease, Pharmacology, Placebo, Psychedelics and Drug Studies, Pain Management and Placebo Effect, Digital Mental Health Interventions", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7117964120\",\"openalex_url\":\"https://openalex.org/W7117964120\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"compound:comp360\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121770090\",\"display_name\":\"N. Mcgowan\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121788394\",\"display_name\":\"J. Rucker\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121776293\",\"display_name\":\"R. Yehuda\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121806605\",\"display_name\":\"M. Agrawal\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121802584\",\"display_name\":\"H. Simmons\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121797777\",\"display_name\":\"S. Das\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121813176\",\"display_name\":\"G. Goodwin\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106821\",\"is_oa\":true}}", "topic_tags": "Depression,PTSD,Chronic Pain,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7117964120" }, { "id": 4153, "title": "Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression", "normalized_title": "relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment resistant depression", "authors": "L. Puhl, L. Kunz, M. Berger, G. Gründer, L. Mertens, M. Spangemacher", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106390", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.106390", "keywords": "Psilocybin, Depression (economics), Medicine, Psychiatry, Hallucinogen, Psychology, Clinical psychology, Anxiety, Disease, Affect (linguistics), Cognition, Psychedelics and Drug Studies, Pain Management and Placebo Effect, Forensic Toxicology and Drug Analysis", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7117961846\",\"openalex_url\":\"https://openalex.org/W7117961846\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121762326\",\"display_name\":\"L. Puhl\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121759413\",\"display_name\":\"L. Kunz\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121760402\",\"display_name\":\"M. Berger\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121772024\",\"display_name\":\"G. Gründer\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121809489\",\"display_name\":\"L. Mertens\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121826605\",\"display_name\":\"M. Spangemacher\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106390\",\"is_oa\":true}}", "topic_tags": "Depression,Anxiety,Chronic Pain,Treatment-Resistant Depression,Toxicity", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7117961846" }, { "id": 2001, "title": "Preclinical evaluation of psilocybin as an anti-inflammatory agent", "normalized_title": "preclinical evaluation of psilocybin as an anti inflammatory agent", "authors": "N. Martínez-Álvarez, I. Erkizia-Santamaría, A. Tomás-Alvarado, A.M. Erdozain, J.J. Meana, J.E. Ortega", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105853", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.105853", "keywords": "Psilocybin, Medicine, Pharmacology, Neuroscience, Drug, Hallucinogen, Riluzole, Chemistry, Disease, Computer science, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Pain Management and Placebo Effect", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7118009135\",\"openalex_url\":\"https://openalex.org/W7118009135\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121773140\",\"display_name\":\"N. Martínez-Álvarez\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121779293\",\"display_name\":\"I. Erkizia-Santamaría\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121780610\",\"display_name\":\"A. Tomás-Alvarado\",\"orcid\":null},{\"id\":\"https://openalex.org/A5030341011\",\"display_name\":\"A.M. Erdozain\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121834541\",\"display_name\":\"J.J. Meana\",\"orcid\":null},{\"id\":\"https://openalex.org/A5105369889\",\"display_name\":\"J.E. Ortega\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105853\",\"is_oa\":true}}", "topic_tags": "Chronic Pain,Pharmacology,Animal Study,Toxicity,Inflammation", "study_type": "Animal Study", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7118009135" }, { "id": 2000, "title": "Psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to music", "normalized_title": "psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to music", "authors": "M. Benes, D. Gregus, P. Adamek, T. Páleníček, J. Horacek", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106823", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.106823", "keywords": "Psychology, Active listening, Psilocybin, Cognitive psychology, Developmental psychology, Social psychology, Cognition, Communication, Affect (linguistics), Audiology, Psychedelics and Drug Studies, Nicotinic Acetylcholine Receptors Study, Cannabis and Cannabinoid Research", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7118007847\",\"openalex_url\":\"https://openalex.org/W7118007847\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121820960\",\"display_name\":\"M. Benes\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121754529\",\"display_name\":\"D. Gregus\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121829256\",\"display_name\":\"P. Adamek\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121832941\",\"display_name\":\"T. Páleníček\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121831014\",\"display_name\":\"J. Horacek\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106823\",\"is_oa\":true}}", "topic_tags": "Receptor Pharmacology,Healthy Volunteers", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7118007847" }, { "id": 1998, "title": "Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adults", "normalized_title": "effects of low dose psilocybin on eeg markers of sensory processing in autistic and non autistic adults", "authors": "O. Ollari, T.P. Whelan, C.L. Ellis, N. Khalil, F. Moruzzi, D.G.M. Murphy, E. Daly, L. Mason, N. Puts, G.M. McAlonan", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2026.106903", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2026.106903", "keywords": "Psilocybin, Electroencephalography, Neuroscience, Sensory processing, Medicine, Sensory system, Audiology, Psychology, Schizophrenia (object-oriented programming), Electrophysiology, Neural activity, Hallucinogen, Neurophysiology, Cognition, Psychedelics and Drug Studies, Paranormal Experiences and Beliefs, Pain Management and Placebo Effect", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7161753513\",\"openalex_url\":\"https://openalex.org/W7161753513\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5136578997\",\"display_name\":\"O. Ollari\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136531578\",\"display_name\":\"T.P. Whelan\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121799276\",\"display_name\":\"C.L. Ellis\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121759661\",\"display_name\":\"N. Khalil\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121833749\",\"display_name\":\"F. Moruzzi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121832208\",\"display_name\":\"D.G.M. Murphy\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136522615\",\"display_name\":\"E. Daly\",\"orcid\":null},{\"id\":\"https://openalex.org/A5136562256\",\"display_name\":\"L. Mason\",\"orcid\":null},{\"id\":\"https://openalex.org/A5129790138\",\"display_name\":\"N. Puts\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121782292\",\"display_name\":\"G.M. McAlonan\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2026.106903\",\"is_oa\":true}}", "topic_tags": "Chronic Pain,Brain Imaging,Biomarkers", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7161753513" }, { "id": 1997, "title": "Mismatch between psilocybin-induced head-twitch behaviour and psilocin brain levels in mice", "normalized_title": "mismatch between psilocybin induced head twitch behaviour and psilocin brain levels in mice", "authors": "F. Sellitti, C. Weber, É. Tamura, Z. Li, J. Thomann, D. Luethi, L.D. Simmler", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106574", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.106574", "keywords": "Chemistry, Central nervous system, Biology, Neuroscience, Molecular biology, Cell biology, Nervous system, Biochemistry, Immune system, Component (thermodynamics), Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs", "substance_tags": "psilocybin,psilocin", "source_name": "OpenAlex", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7118009596\",\"openalex_url\":\"https://openalex.org/W7118009596\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"title:psilocin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121758920\",\"display_name\":\"F. Sellitti\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121817927\",\"display_name\":\"C. Weber\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121778565\",\"display_name\":\"É. Tamura\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121777883\",\"display_name\":\"Z. Li\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121827508\",\"display_name\":\"J. Thomann\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121809251\",\"display_name\":\"D. Luethi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121763859\",\"display_name\":\"L.D. Simmler\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106574\",\"is_oa\":true}}", "topic_tags": "Animal Study,Toxicity,Immune Function", "study_type": "Animal Study", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7118009596" }, { "id": 1996, "title": "Preliminary results from an ongoing naturalistic survey study investigating dose-finding practices and effects of self-administered small amounts of psilocybin", "normalized_title": "preliminary results from an ongoing naturalistic survey study investigating dose finding practices and effects of self administered small amounts of psilocybin", "authors": "I. Totomanova, E.C.H.M. Haijen, Petra P. M. Hurks, NL Mason, K.P.C. Kuypers", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106822", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.106822", "keywords": "Psilocybin, Psychology, Survey research, Naturalistic observation, Data collection, Applied psychology, Clinical psychology, Spouse, Social psychology, Affect (linguistics), Empirical research, Survey data collection, Naturalism, Research methodology, Research design, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7117971009\",\"openalex_url\":\"https://openalex.org/W7117971009\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121833055\",\"display_name\":\"I. Totomanova\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121779284\",\"display_name\":\"E.C.H.M. Haijen\",\"orcid\":null},{\"id\":\"https://openalex.org/A5074444381\",\"display_name\":\"Petra P. M. Hurks\",\"orcid\":\"https://orcid.org/0000-0002-4366-3707\"},{\"id\":\"https://openalex.org/A5110749453\",\"display_name\":\"NL Mason\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121765730\",\"display_name\":\"K.P.C. Kuypers\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106822\",\"is_oa\":true}}", "topic_tags": "Observational Study,Toxicity", "study_type": "Observational Study", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7117971009" }, { "id": 1995, "title": "Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in humans", "normalized_title": "temporal effects of a single oral dose of psilocybin on plasma circulating mirnas in humans", "authors": "A. O'shea, JG Ramaekers, R. Schreiber, J.J. Briedé, J. Krauskopf, N. Mason, M.C.T. Verheijen", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106576", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.106576", "keywords": "Psilocybin, Medicine, Pharmacology, microRNA, Internal medicine, Endocrinology, Chemistry, Drug, Pharmacokinetics, Plasma concentration, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7117995674\",\"openalex_url\":\"https://openalex.org/W7117995674\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121784560\",\"display_name\":\"A. O'shea\",\"orcid\":null},{\"id\":\"https://openalex.org/A5103425123\",\"display_name\":\"JG Ramaekers\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121806731\",\"display_name\":\"R. Schreiber\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121785178\",\"display_name\":\"J.J. Briedé\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121770613\",\"display_name\":\"J. Krauskopf\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121821037\",\"display_name\":\"N. Mason\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121795820\",\"display_name\":\"M.C.T. Verheijen\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106576\",\"is_oa\":true}}", "topic_tags": "Pharmacology,Toxicity", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7117995674" }, { "id": 1994, "title": "Behavioral and neuronal effects of psilocybin in mice", "normalized_title": "behavioral and neuronal effects of psilocybin in mice", "authors": "C. Weber, F. Sellitti, L. Ziming, J. von Arx, L.D. Simmler", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106575", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.106575", "keywords": "Neuroscience, Psilocybin, Central nervous system, Chemistry, Medicine, Pharmacology, Hallucinogen, Midbrain, Biology, Neural activity, Psychedelics and Drug Studies, Forensic Toxicology and Drug Analysis, Paranormal Experiences and Beliefs", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "raw_json": "{\"openalex_id\":\"https://openalex.org/W7118002886\",\"openalex_url\":\"https://openalex.org/W7118002886\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5121817927\",\"display_name\":\"C. Weber\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121758920\",\"display_name\":\"F. Sellitti\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121800044\",\"display_name\":\"L. Ziming\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121803567\",\"display_name\":\"J. von Arx\",\"orcid\":null},{\"id\":\"https://openalex.org/A5121763859\",\"display_name\":\"L.D. Simmler\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.106575\",\"is_oa\":true}}", "topic_tags": "Pharmacology,Animal Study,Toxicity", "study_type": "Animal Study", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W7118002886" }, { "id": 4475, "title": "Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression", "normalized_title": "effects of escitalopram and psilocybin therapy on mesolimbic resting state functional connectivity in depression", "authors": "Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1016/j.nsa.2025.105421", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.105421", "keywords": "Psilocybin, Escitalopram, Functional connectivity, Depression (economics), Psychology, Neuroscience, Hallucinogen, Resting state fMRI, Psychiatry, Antidepressant, Hippocampus, Macroeconomics, Economics, Psychedelics and Drug Studies, Mental Health Research Topics, Biofield Effects and Biophysics", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4408526135\",\"openalex_url\":\"https://openalex.org/W4408526135\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5110297305\",\"display_name\":\"Rebecca Harding\",\"orcid\":\"https://orcid.org/0009-0008-2701-6930\"},{\"id\":\"https://openalex.org/A5004040027\",\"display_name\":\"Natalie Ertl\",\"orcid\":\"https://orcid.org/0000-0002-9010-1870\"},{\"id\":\"https://openalex.org/A5081484066\",\"display_name\":\"Rabia Zafar\",\"orcid\":\"https://orcid.org/0000-0002-3515-7441\"},{\"id\":\"https://openalex.org/A5109938758\",\"display_name\":\"Magnus Wall\",\"orcid\":null},{\"id\":\"https://openalex.org/A5110486366\",\"display_name\":\"Rajkanya Das\",\"orcid\":\"https://orcid.org/0009-0009-3650-1847\"},{\"id\":\"https://openalex.org/A5044907549\",\"display_name\":\"David Erritzøe\",\"orcid\":\"https://orcid.org/0000-0002-7022-6211\"},{\"id\":\"https://openalex.org/A5101507504\",\"display_name\":\"David Nutt\",\"orcid\":\"https://orcid.org/0000-0002-6423-9411\"},{\"id\":\"https://openalex.org/A5038609897\",\"display_name\":\"Robin Carhart-Harris\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105421\",\"is_oa\":true}}", "topic_tags": "Depression,Brain Imaging", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4408526135" }, { "id": 4474, "title": "Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behavior", "normalized_title": "long term effects of single dose psilocybin and psychedelic mushroom extract in the sapap3 model of ocd like behavior", "authors": "Michal Brownstien", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1016/j.nsa.2025.105450", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.105450", "keywords": "Psilocybin, Hallucinogen, Term (time), Psychology, Mushroom, Cognitive psychology, Psychiatry, Chemistry, Physics, Food science, Quantum mechanics, Psychedelics and Drug Studies, Sexuality, Behavior, and Technology, Neurotransmitter Receptor Influence on Behavior", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4408525624\",\"openalex_url\":\"https://openalex.org/W4408525624\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"contextual-mushroom-match\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5066003352\",\"display_name\":\"Michal Brownstien\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105450\",\"is_oa\":true}}", "topic_tags": "OCD,Receptor Pharmacology", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4408525624" }, { "id": 769, "title": "Is there room for ethics of authenticity in psilocybin research?", "normalized_title": "is there room for ethics of authenticity in psilocybin research", "authors": "Stefan Jerotić", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1016/j.nsa.2025.105519", "pubmed_id": "40654595", "source_url": "https://doi.org/10.1016/j.nsa.2025.105519", "keywords": "Psilocybin, Psychology, Psychoanalysis, Sociology, Engineering ethics, Hallucinogen, Psychiatry, Engineering, Psychedelics and Drug Studies, Chemical synthesis and alkaloids, Diverse academic research themes", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4408829649\",\"openalex_url\":\"https://openalex.org/W4408829649\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":2,\"referenced_works\":[\"https://openalex.org/W2118739111\",\"https://openalex.org/W2127389211\",\"https://openalex.org/W2624535799\",\"https://openalex.org/W2759559981\",\"https://openalex.org/W4283211919\",\"https://openalex.org/W4392883849\",\"https://openalex.org/W4400848963\",\"https://openalex.org/W4404933083\",\"https://openalex.org/W6874464476\"],\"authorships\":[{\"id\":\"https://openalex.org/A5069503298\",\"display_name\":\"Stefan Jerotić\",\"orcid\":\"https://orcid.org/0000-0002-7784-0249\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2025.105519\",\"is_oa\":true}}", "topic_tags": "General", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4408829649" }, { "id": 4713, "title": "Changes in positive and negative affect in participants with treatment-resistant depression following COMP360 psilocybin treatment", "normalized_title": "changes in positive and negative affect in participants with treatment resistant depression following comp360 psilocybin treatment", "authors": "Matthew B. Young, J. Chai-Rees, Anna Nowakowska, Jeng-Yu Tsai, Guy M. Goodwin", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104163", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2024.104163", "keywords": "Psilocybin, Affect (linguistics), Depression (economics), Psychology, Treatment-resistant depression, Clinical psychology, Psychotherapist, Psychiatry, Hallucinogen, Major depressive disorder, Mood, Communication, Economics, Macroeconomics, Psychedelics and Drug Studies, Psychotherapy Techniques and Applications, Mental Health Research Topics", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4405637298\",\"openalex_url\":\"https://openalex.org/W4405637298\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"compound:comp360\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5091177873\",\"display_name\":\"Matthew B. Young\",\"orcid\":\"https://orcid.org/0000-0002-6077-3190\"},{\"id\":\"https://openalex.org/A5093581995\",\"display_name\":\"J. Chai-Rees\",\"orcid\":null},{\"id\":\"https://openalex.org/A5036831540\",\"display_name\":\"Anna Nowakowska\",\"orcid\":\"https://orcid.org/0000-0003-4016-1522\"},{\"id\":\"https://openalex.org/A5008221825\",\"display_name\":\"Jeng-Yu Tsai\",\"orcid\":\"https://orcid.org/0000-0002-8657-3744\"},{\"id\":\"https://openalex.org/A5037628078\",\"display_name\":\"Guy M. Goodwin\",\"orcid\":\"https://orcid.org/0000-0002-1426-2816\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2024.104163\",\"is_oa\":true}}", "topic_tags": "Depression,Treatment-Resistant Depression", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4405637298" }, { "id": 4712, "title": "Psilocybin vs Escitalopram for depression: 6-month follow-up", "normalized_title": "psilocybin vs escitalopram for depression 6 month follow up", "authors": "Thomas Barba, David Erritzøe, Kyle T. Greenway, Rinki Murphy, John Martell, Christopher Timmermann, Ashleigh Murphy-Beiner, Bruna Giribaldi, Michelle Baker Jones, Brandon Weiss, Robin Carhart-Harris", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104377", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2024.104377", "keywords": "Psilocybin, Escitalopram, Depression (economics), Psychiatry, Hallucinogen, Psychology, Medicine, Antidepressant, Anxiety, Economics, Macroeconomics, Psychedelics and Drug Studies, Chemical synthesis and alkaloids", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4405637013\",\"openalex_url\":\"https://openalex.org/W4405637013\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5019943317\",\"display_name\":\"Thomas Barba\",\"orcid\":\"https://orcid.org/0000-0003-1281-0433\"},{\"id\":\"https://openalex.org/A5044907549\",\"display_name\":\"David Erritzøe\",\"orcid\":\"https://orcid.org/0000-0002-7022-6211\"},{\"id\":\"https://openalex.org/A5086630833\",\"display_name\":\"Kyle T. Greenway\",\"orcid\":\"https://orcid.org/0000-0002-7829-493X\"},{\"id\":\"https://openalex.org/A5026838445\",\"display_name\":\"Rinki Murphy\",\"orcid\":\"https://orcid.org/0000-0002-0043-2423\"},{\"id\":\"https://openalex.org/A5108297314\",\"display_name\":\"John Martell\",\"orcid\":null},{\"id\":\"https://openalex.org/A5055329548\",\"display_name\":\"Christopher Timmermann\",\"orcid\":\"https://orcid.org/0000-0002-2281-377X\"},{\"id\":\"https://openalex.org/A5020659258\",\"display_name\":\"Ashleigh Murphy-Beiner\",\"orcid\":null},{\"id\":\"https://openalex.org/A5061472267\",\"display_name\":\"Bruna Giribaldi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5113396956\",\"display_name\":\"Michelle Baker Jones\",\"orcid\":null},{\"id\":\"https://openalex.org/A5015600817\",\"display_name\":\"Brandon Weiss\",\"orcid\":\"https://orcid.org/0000-0003-2989-2981\"},{\"id\":\"https://openalex.org/A5038609897\",\"display_name\":\"Robin Carhart-Harris\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2024.104377\",\"is_oa\":true}}", "topic_tags": "Depression,Anxiety", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4405637013" }, { "id": 4711, "title": "Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patients", "normalized_title": "effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patients", "authors": "Kristoffer Brendstrup-Brix, Patrick M. Fisher, Dea Siggaard Stenbæk, Anja Sofie Petersen, Stéphane Armand, Drummond E-Wen McCulloch, Maja Rou Marstrand-Joergensen, Sara Marie Ulv Larsen, Annette Johansen, Rigmor Jensen, Gitte M. Knudsen, M. Madsen", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.105131", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2024.105131", "keywords": "Cluster headache, Psilocybin, Sleep quality, Sleep (system call), Medicine, Cluster (spacecraft), Psychology, Psychiatry, Insomnia, Hallucinogen, Migraine, Computer science, Operating system, Programming language, Psychedelics and Drug Studies, Pain Management and Placebo Effect, Paranormal Experiences and Beliefs", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4405636342\",\"openalex_url\":\"https://openalex.org/W4405636342\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5054721141\",\"display_name\":\"Kristoffer Brendstrup-Brix\",\"orcid\":\"https://orcid.org/0009-0006-8683-4277\"},{\"id\":\"https://openalex.org/A5021085020\",\"display_name\":\"Patrick M. Fisher\",\"orcid\":\"https://orcid.org/0000-0002-8115-0611\"},{\"id\":\"https://openalex.org/A5004791170\",\"display_name\":\"Dea Siggaard Stenbæk\",\"orcid\":\"https://orcid.org/0000-0002-5439-4637\"},{\"id\":\"https://openalex.org/A5089756098\",\"display_name\":\"Anja Sofie Petersen\",\"orcid\":\"https://orcid.org/0000-0002-0125-6038\"},{\"id\":\"https://openalex.org/A5014613835\",\"display_name\":\"Stéphane Armand\",\"orcid\":\"https://orcid.org/0000-0001-9144-4982\"},{\"id\":\"https://openalex.org/A5064300685\",\"display_name\":\"Drummond E-Wen McCulloch\",\"orcid\":\"https://orcid.org/0000-0001-6360-5224\"},{\"id\":\"https://openalex.org/A5031514106\",\"display_name\":\"Maja Rou Marstrand-Joergensen\",\"orcid\":\"https://orcid.org/0000-0002-2833-7823\"},{\"id\":\"https://openalex.org/A5077640621\",\"display_name\":\"Sara Marie Ulv Larsen\",\"orcid\":\"https://orcid.org/0000-0002-9046-2430\"},{\"id\":\"https://openalex.org/A5072267838\",\"display_name\":\"Annette Johansen\",\"orcid\":\"https://orcid.org/0000-0003-0264-2368\"},{\"id\":\"https://openalex.org/A5018165002\",\"display_name\":\"Rigmor Jensen\",\"orcid\":\"https://orcid.org/0000-0001-6433-5887\"},{\"id\":\"https://openalex.org/A5015895924\",\"display_name\":\"Gitte M. Knudsen\",\"orcid\":\"https://orcid.org/0000-0003-1508-6866\"},{\"id\":\"https://openalex.org/A5000203733\",\"display_name\":\"M. Madsen\",\"orcid\":\"https://orcid.org/0000-0001-8836-1844\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2024.105131\",\"is_oa\":true}}", "topic_tags": "Chronic Pain,Headache / Migraine", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4405636342" }, { "id": 4710, "title": "Neural effects of psilocybin-treatment in patients with treatment-resistant depression", "normalized_title": "neural effects of psilocybin treatment in patients with treatment resistant depression", "authors": "C. Schmitz, Hana Adolphi, Michael Frank, E. Seeger, Maciej Musiał, Moritz Spangemacher, Michael Koslowski, Lea J. Mertens, Florian Schlagenhauf, Gerhard Gründer", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.105028", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2024.105028", "keywords": "Psilocybin, Treatment-resistant depression, Depression (economics), Medicine, Hallucinogen, Psychology, Psychotherapist, Psychiatry, Antidepressant, Anxiety, Keynesian economics, Economics, Psychedelics and Drug Studies, Chemical synthesis and alkaloids, Psychotherapy Techniques and Applications", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4405635994\",\"openalex_url\":\"https://openalex.org/W4405635994\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":null,\"display_name\":\"C. Schmitz\",\"orcid\":null},{\"id\":\"https://openalex.org/A5115564029\",\"display_name\":\"Hana Adolphi\",\"orcid\":null},{\"id\":\"https://openalex.org/A5033477592\",\"display_name\":\"Michael Frank\",\"orcid\":\"https://orcid.org/0000-0001-8449-237X\"},{\"id\":\"https://openalex.org/A5115564030\",\"display_name\":\"E. Seeger\",\"orcid\":null},{\"id\":\"https://openalex.org/A5006755636\",\"display_name\":\"Maciej Musiał\",\"orcid\":\"https://orcid.org/0000-0002-9519-7429\"},{\"id\":\"https://openalex.org/A5070750577\",\"display_name\":\"Moritz Spangemacher\",\"orcid\":null},{\"id\":\"https://openalex.org/A5045306689\",\"display_name\":\"Michael Koslowski\",\"orcid\":\"https://orcid.org/0000-0001-8798-9875\"},{\"id\":\"https://openalex.org/A5070309082\",\"display_name\":\"Lea J. Mertens\",\"orcid\":\"https://orcid.org/0000-0003-4415-3941\"},{\"id\":\"https://openalex.org/A5066569532\",\"display_name\":\"Florian Schlagenhauf\",\"orcid\":\"https://orcid.org/0000-0001-8340-5027\"},{\"id\":\"https://openalex.org/A5081339058\",\"display_name\":\"Gerhard Gründer\",\"orcid\":\"https://orcid.org/0000-0001-7868-3903\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2024.105028\",\"is_oa\":true}}", "topic_tags": "Depression,Anxiety,Treatment-Resistant Depression", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4405635994" }, { "id": 4709, "title": "Insights into the serotonergic mechanisms of psilocybin-induced improvements in anorexia-like behaviour in female rats", "normalized_title": "insights into the serotonergic mechanisms of psilocybin induced improvements in anorexia like behaviour in female rats", "authors": "Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Jaana Ruuska, Mónica Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104774", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2024.104774", "keywords": "Psilocybin, Serotonergic, Anorexia, Hallucinogen, Psychology, Neuroscience, Medicine, Serotonin, Psychotherapist, Psychiatry, Internal medicine, Receptor, Psychedelics and Drug Studies, Neurotransmitter Receptor Influence on Behavior, Cannabis and Cannabinoid Research", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4405621760\",\"openalex_url\":\"https://openalex.org/W4405621760\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5016384733\",\"display_name\":\"Kyna-Anne Conn\",\"orcid\":\"https://orcid.org/0000-0003-2244-7885\"},{\"id\":\"https://openalex.org/A5010010872\",\"display_name\":\"Laura K Milton\",\"orcid\":\"https://orcid.org/0009-0007-1664-8337\"},{\"id\":\"https://openalex.org/A5061059143\",\"display_name\":\"Kaixin Huang\",\"orcid\":\"https://orcid.org/0000-0002-9746-7947\"},{\"id\":\"https://openalex.org/A5044072275\",\"display_name\":\"Hermany Munguba\",\"orcid\":\"https://orcid.org/0000-0002-8480-8423\"},{\"id\":\"https://openalex.org/A5082127649\",\"display_name\":\"Jaana Ruuska\",\"orcid\":null},{\"id\":\"https://openalex.org/A5015404689\",\"display_name\":\"Mónica Lemus\",\"orcid\":\"https://orcid.org/0000-0001-9536-3020\"},{\"id\":\"https://openalex.org/A5045433632\",\"display_name\":\"Erin Greaves\",\"orcid\":\"https://orcid.org/0000-0001-9165-5851\"},{\"id\":\"https://openalex.org/A5039407232\",\"display_name\":\"Jihane Homman-Ludiye\",\"orcid\":\"https://orcid.org/0000-0001-6689-1457\"},{\"id\":\"https://openalex.org/A5041876284\",\"display_name\":\"Brian J. Oldfield\",\"orcid\":\"https://orcid.org/0000-0002-8609-6589\"},{\"id\":\"https://openalex.org/A5003584852\",\"display_name\":\"Claire J. Foldi\",\"orcid\":\"https://orcid.org/0000-0002-3293-8242\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2024.104774\",\"is_oa\":true}}", "topic_tags": "Eating Disorders,Mechanism of Action,Receptor Pharmacology", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4405621760" }, { "id": 4708, "title": "Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patients", "normalized_title": "associations between behavioral and neuronal changes in self referential processing following a single moderate dose of psilocybin in depressed patients", "authors": "L. Belinger, Flora Moujaes, Robin von Rotz, Nathalie M. Rieser, Marcus Herdener, Franz X. Vollenweider, Katrin H. Preller", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104768", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2024.104768", "keywords": "Psilocybin, Hallucinogen, Psychology, Clinical psychology, Neuroscience, Psychiatry, Psychedelics and Drug Studies, Mental Health and Psychiatry, Psychotherapy Techniques and Applications", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4405621752\",\"openalex_url\":\"https://openalex.org/W4405621752\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5093582321\",\"display_name\":\"L. Belinger\",\"orcid\":null},{\"id\":\"https://openalex.org/A5039540919\",\"display_name\":\"Flora Moujaes\",\"orcid\":\"https://orcid.org/0000-0002-0843-0393\"},{\"id\":\"https://openalex.org/A5058976475\",\"display_name\":\"Robin von Rotz\",\"orcid\":\"https://orcid.org/0000-0003-4087-3650\"},{\"id\":\"https://openalex.org/A5050105328\",\"display_name\":\"Nathalie M. Rieser\",\"orcid\":\"https://orcid.org/0000-0002-5804-1409\"},{\"id\":\"https://openalex.org/A5005591219\",\"display_name\":\"Marcus Herdener\",\"orcid\":\"https://orcid.org/0000-0001-5830-1971\"},{\"id\":\"https://openalex.org/A5086283052\",\"display_name\":\"Franz X. Vollenweider\",\"orcid\":\"https://orcid.org/0000-0001-9053-6164\"},{\"id\":\"https://openalex.org/A5040977207\",\"display_name\":\"Katrin H. Preller\",\"orcid\":\"https://orcid.org/0000-0003-0413-7672\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2024.104768\",\"is_oa\":true}}", "topic_tags": "General", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4405621752" }, { "id": 4707, "title": "Evaluation of the long-term cognitive effects of psilocybin in a chronic stress mouse model", "normalized_title": "evaluation of the long term cognitive effects of psilocybin in a chronic stress mouse model", "authors": "Nerea Martínez-Álvarez, Ines Erkizia-Santamaría, Elena Hernández-Hernández, Amaia M. Erdozain, J. Javier Meana, J.E. Ortega", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104783", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2024.104783", "keywords": "Psilocybin, Term (time), Cognition, Psychology, Chronic stress, Cognitive psychology, Clinical psychology, Neuroscience, Psychotherapist, Psychiatry, Hallucinogen, Physics, Quantum mechanics, Psychedelics and Drug Studies, Mental Health Research Topics, Tryptophan and brain disorders", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4405621732\",\"openalex_url\":\"https://openalex.org/W4405621732\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5115558540\",\"display_name\":\"Nerea Martínez-Álvarez\",\"orcid\":null},{\"id\":\"https://openalex.org/A5064629089\",\"display_name\":\"Ines Erkizia-Santamaría\",\"orcid\":\"https://orcid.org/0000-0002-6163-4571\"},{\"id\":\"https://openalex.org/A5015204327\",\"display_name\":\"Elena Hernández-Hernández\",\"orcid\":\"https://orcid.org/0000-0003-3714-0181\"},{\"id\":\"https://openalex.org/A5000178647\",\"display_name\":\"Amaia M. Erdozain\",\"orcid\":\"https://orcid.org/0000-0003-0207-9122\"},{\"id\":\"https://openalex.org/A5024198476\",\"display_name\":\"J. Javier Meana\",\"orcid\":\"https://orcid.org/0000-0002-7913-6714\"},{\"id\":\"https://openalex.org/A5105369889\",\"display_name\":\"J.E. Ortega\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2024.104783\",\"is_oa\":true}}", "topic_tags": "Animal Study", "study_type": "Animal Study", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4405621732" }, { "id": 4699, "title": "Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapy", "normalized_title": "exploring the molecular basis of treatment resistant depression discoveries from a rat model and psilocybin therapy", "authors": "Agata Korlatowicz, Katarzyna Latocha, Paulina Pabian, Ryszard Bugno, Adam S. Hogendorf, Tamás Kovács, Andrzej J. Bojarski, Zoltán V. Varga, Agata Faron-Górecka", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104020", "pubmed_id": null, "source_url": "http://dx.doi.org/10.1016/j.nsa.2024.104020", "keywords": "Psilocybin, Depression (economics), Treatment-resistant depression, Psychotherapist, Psychology, Basis (linear algebra), Hallucinogen, Neuroscience, Psychiatry, Major depressive disorder, Mathematics, Economics, Cognition, Macroeconomics, Geometry, Psychedelics and Drug Studies, Neurotransmitter Receptor Influence on Behavior, Mental Health Research Topics", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4392405867\",\"openalex_url\":\"https://openalex.org/W4392405867\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5073055765\",\"display_name\":\"Agata Korlatowicz\",\"orcid\":\"https://orcid.org/0000-0002-8926-3143\"},{\"id\":\"https://openalex.org/A5023980590\",\"display_name\":\"Katarzyna Latocha\",\"orcid\":\"https://orcid.org/0000-0001-7146-6922\"},{\"id\":\"https://openalex.org/A5010694343\",\"display_name\":\"Paulina Pabian\",\"orcid\":\"https://orcid.org/0000-0002-3449-5318\"},{\"id\":\"https://openalex.org/A5006523340\",\"display_name\":\"Ryszard Bugno\",\"orcid\":\"https://orcid.org/0000-0003-3741-674X\"},{\"id\":\"https://openalex.org/A5034604911\",\"display_name\":\"Adam S. Hogendorf\",\"orcid\":\"https://orcid.org/0000-0003-3311-3266\"},{\"id\":\"https://openalex.org/A5101605265\",\"display_name\":\"Tamás Kovács\",\"orcid\":\"https://orcid.org/0000-0003-4127-4545\"},{\"id\":\"https://openalex.org/A5025399512\",\"display_name\":\"Andrzej J. Bojarski\",\"orcid\":\"https://orcid.org/0000-0003-1417-6333\"},{\"id\":\"https://openalex.org/A5059550755\",\"display_name\":\"Zoltán V. Varga\",\"orcid\":\"https://orcid.org/0000-0002-2758-0784\"},{\"id\":\"https://openalex.org/A5027636060\",\"display_name\":\"Agata Faron-Górecka\",\"orcid\":\"https://orcid.org/0000-0002-8202-190X\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"http://dx.doi.org/10.1016/j.nsa.2024.104020\",\"is_oa\":true}}", "topic_tags": "Depression,Receptor Pharmacology,Animal Study,Treatment-Resistant Depression", "study_type": "Animal Study", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4392405867" }, { "id": 4696, "title": "Investigational COMP360 psilocybin treatment for treatment-resistant depression: assessing altered states of consciousness", "normalized_title": "investigational comp360 psilocybin treatment for treatment resistant depression assessing altered states of consciousness", "authors": "N. Hewitt, J. Chai-Rees, Megan Croal, S. Mistry, Jeng-Yu Tsai, Matthew B. Young, Guy M. Goodwin", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104391", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2024.104391", "keywords": "Psilocybin, Altered state, Depression (economics), Consciousness, Psychology, Treatment-resistant depression, Psychotherapist, Psychiatry, Hallucinogen, Psychoanalysis, Neuroscience, Antidepressant, Anxiety, Macroeconomics, Economics, Psychedelics and Drug Studies, Digital Mental Health Interventions, Paranormal Experiences and Beliefs", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4405660466\",\"openalex_url\":\"https://openalex.org/W4405660466\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"compound:comp360\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":1,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5039824360\",\"display_name\":\"N. Hewitt\",\"orcid\":null},{\"id\":\"https://openalex.org/A5093581995\",\"display_name\":\"J. Chai-Rees\",\"orcid\":null},{\"id\":\"https://openalex.org/A5072218538\",\"display_name\":\"Megan Croal\",\"orcid\":\"https://orcid.org/0000-0002-3286-1003\"},{\"id\":\"https://openalex.org/A5016967968\",\"display_name\":\"S. Mistry\",\"orcid\":null},{\"id\":\"https://openalex.org/A5008221825\",\"display_name\":\"Jeng-Yu Tsai\",\"orcid\":\"https://orcid.org/0000-0002-8657-3744\"},{\"id\":\"https://openalex.org/A5091177873\",\"display_name\":\"Matthew B. Young\",\"orcid\":\"https://orcid.org/0000-0002-6077-3190\"},{\"id\":\"https://openalex.org/A5037628078\",\"display_name\":\"Guy M. Goodwin\",\"orcid\":\"https://orcid.org/0000-0002-1426-2816\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2024.104391\",\"is_oa\":true}}", "topic_tags": "Depression,Anxiety,Consciousness,Treatment-Resistant Depression", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4405660466" }, { "id": 2008, "title": "Pharmacological characterization of psilocin affinity towards different 5-HT receptors and receptor regulation after psilocybin administration in pigs", "normalized_title": "pharmacological characterization of psilocin affinity towards different 5 ht receptors and receptor regulation after psilocybin administration in pigs", "authors": "Ewald Kolesnik, Ma Luisa Masó Navarro, Nakul Ravi Raval, Brice Ozenne, Hanne D. Hansen", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.105133", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2024.105133", "keywords": "Psilocybin, Receptor, 5-HT receptor, Hallucinogen, Pharmacology, 5-HT2 receptor, Chemistry, Psychology, Serotonin, Biology, Biochemistry, Psychedelics and Drug Studies, Neurotransmitter Receptor Influence on Behavior, Cannabis and Cannabinoid Research", "substance_tags": "psilocybin,psilocin", "source_name": "OpenAlex", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4405636234\",\"openalex_url\":\"https://openalex.org/W4405636234\",\"openalex_relevance_score\":10,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"title:psilocin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5003796858\",\"display_name\":\"Ewald Kolesnik\",\"orcid\":\"https://orcid.org/0000-0002-9349-8068\"},{\"id\":\"https://openalex.org/A5103462312\",\"display_name\":\"Ma Luisa Masó Navarro\",\"orcid\":null},{\"id\":\"https://openalex.org/A5016318094\",\"display_name\":\"Nakul Ravi Raval\",\"orcid\":\"https://orcid.org/0000-0001-5637-7219\"},{\"id\":\"https://openalex.org/A5021739634\",\"display_name\":\"Brice Ozenne\",\"orcid\":\"https://orcid.org/0000-0001-9694-2956\"},{\"id\":\"https://openalex.org/A5005785269\",\"display_name\":\"Hanne D. Hansen\",\"orcid\":\"https://orcid.org/0000-0001-5564-7627\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2024.105133\",\"is_oa\":true}}", "topic_tags": "Pharmacology,Receptor Pharmacology", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4405636234" }, { "id": 1196, "title": "Safety pharmacology of acute psilocybin administration in healthy participants", "normalized_title": "safety pharmacology of acute psilocybin administration in healthy participants", "authors": "Isabelle Straumann, Friederike Holze, A. Becker, Laura Ley, Nepomuk Halter, Matthias E. Liechti", "abstract": "Psilocybin is being studied for its therapeutic potential in various mental health disorders, such as depression, anxiety, and addiction. Initial studies suggested that psilocybin is generally safe when used under controlled conditions, but more research is needed to better understand its safety profile. We report safety pharmacology data from a pooled analysis of three randomized crossover studies that included 85 healthy participants and 113 single-dose administrations of psilocybin. Single oral doses included 15 mg, 20 mg, 25 mg, and 30 mg psilocybin dihydrate. We investigated subjective effects, blood pressure, heart rate, body temperature, acute and subacute adverse effects, reports of flashbacks, and liver and kidney function before and after the studies. The 20, 25, and 30 mg doses of psilocybin produced stronger effects than the 15 mg dose. Psilocybin at all doses induced higher \"good drug effects\" than \"bad drug effects.\" Only the 25 and 30 mg doses increased anxiety. Psilocybin elevated autonomic effects only moderately. Tachycardia (>100 beats/min) was observed with 7% of all psilocybin administrations. Body temperature >38° was reached in 7%, 9%, 17%, and 32% of the participants with the 15, 20, 25, and 30 mg doses, respectively. Kidney and liver function parameters were unaltered at the end of the study. Five participants (6%) reported transient flashback phenomena. No serious adverse reactions occurred. These findings suggest that a single administration of psilocybin is safe with regard to acute psychological and physical harm in healthy participants in a controlled research setting.", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104060", "pubmed_id": "40656108", "source_url": "https://doi.org/10.1016/j.nsa.2024.104060", "keywords": "Psilocybin, Adverse effect, Hallucinogen, Anxiety, Medicine, Heart rate, Crossover study, Pharmacology, Anesthesia, Safety pharmacology, Psychology, Drug, Psychiatry, Placebo, Internal medicine, Blood pressure, Alternative medicine, Pathology, Psychedelics and Drug Studies, Chemical synthesis and alkaloids, Neurotransmitter Receptor Influence on Behavior", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4392888270\",\"openalex_url\":\"https://openalex.org/W4392888270\",\"openalex_relevance_score\":9,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"abstract:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":23,\"referenced_works\":[\"https://openalex.org/W2001101493\",\"https://openalex.org/W2003424951\",\"https://openalex.org/W2009122980\",\"https://openalex.org/W2022443784\",\"https://openalex.org/W2075969679\",\"https://openalex.org/W2089306255\",\"https://openalex.org/W2096626991\",\"https://openalex.org/W2113099805\",\"https://openalex.org/W2121441663\",\"https://openalex.org/W2140013897\",\"https://openalex.org/W2161950360\",\"https://openalex.org/W2165032621\",\"https://openalex.org/W2396675581\",\"https://openalex.org/W2415329247\",\"https://openalex.org/W2506717582\",\"https://openalex.org/W2513336695\",\"https://openalex.org/W2549202270\",\"https://openalex.org/W2552761136\",\"https://openalex.org/W2558412547\",\"https://openalex.org/W2559739670\",\"https://openalex.org/W2590375860\",\"https://openalex.org/W2756069429\",\"https://openalex.org/W2767725891\",\"https://openalex.org/W2790481213\",\"https://openalex.org/W2792444257\",\"https://openalex.org/W3092027192\",\"https://openalex.org/W3093375227\",\"https://openalex.org/W3093676138\",\"https://openalex.org/W3096208965\",\"https://openalex.org/W3096897894\",\"https://openalex.org/W3105240299\",\"https://openalex.org/W3156937150\",\"https://openalex.org/W3200846882\",\"https://openalex.org/W3213378850\",\"https://openalex.org/W4206965048\",\"https://openalex.org/W4214649547\",\"https://openalex.org/W4220686675\",\"https://openalex.org/W4223893856\",\"https://openalex.org/W4285007883\",\"https://openalex.org/W4292937262\",\"https://openalex.org/W4293194637\",\"https://openalex.org/W4294631080\",\"https://openalex.org/W4308146982\",\"https://openalex.org/W4311205265\",\"https://openalex.org/W4313530670\",\"https://openalex.org/W4378174725\",\"https://openalex.org/W4386305655\",\"https://openalex.org/W6716751055\",\"https://openalex.org/W6839106885\"],\"authorships\":[{\"id\":\"https://openalex.org/A5069070940\",\"display_name\":\"Isabelle Straumann\",\"orcid\":\"https://orcid.org/0009-0008-2952-586X\"},{\"id\":\"https://openalex.org/A5028081191\",\"display_name\":\"Friederike Holze\",\"orcid\":\"https://orcid.org/0000-0003-3143-1519\"},{\"id\":\"https://openalex.org/A5012996786\",\"display_name\":\"A. Becker\",\"orcid\":\"https://orcid.org/0000-0001-5308-7945\"},{\"id\":\"https://openalex.org/A5102828957\",\"display_name\":\"Laura Ley\",\"orcid\":\"https://orcid.org/0009-0003-9881-4693\"},{\"id\":\"https://openalex.org/A5094174389\",\"display_name\":\"Nepomuk Halter\",\"orcid\":null},{\"id\":\"https://openalex.org/A5071962736\",\"display_name\":\"Matthias E. Liechti\",\"orcid\":\"https://orcid.org/0000-0002-1765-9659\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2024.104060\",\"is_oa\":true}}", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4392888270" }, { "id": 1264, "title": "Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals", "normalized_title": "amygdala response to emotional faces following acute administration of psilocybin in healthy individuals", "authors": "Sophia Armand, Kristian Larsen, M. Madsen, Brice Ozenne, Katrin H. Preller, Gitte M. Knudsen, Dea Siggaard Stenbæk, Patrick M. Fisher", "abstract": "The serotonergic psychedelic psilocybin acutely induces changes in emotional states. However, it remains unresolved whether psilocybin acutely modulates emotionally-relevant amygdala reactivity to emotions, a brain region critically involved in emotion processing. Using functional magnetic resonance imaging (fMRI), we examined in 26 healthy individuals whether amygdala responses to angry, fearful and neutral faces differ between acute exposure to psilocybin and at baseline. We also evaluated whether plasma psilocin levels (PPL) and subjective drug intensity (SDI) during psilocybin are related to amygdala responses to emotional faces. We found that amygdala response to angry faces was significantly reduced during exposure to psilocybin as compared to baseline (mean difference = −0.54, PFWER = 0.03), whereas no significant changes in amygdala responses to fearful or neutral faces were observed. We further found that the amygdala response to fearful faces was significantly negatively associated with SDI (slope = −0.13, PFWER = 0.04), whereas no significant association with PPL was observed. Our findings indicate that psilocybin attenuates amygdala reactivity to angry faces and that a more intense subjective psilocybin response (SDI) is associated with attenuated amygdala reactivity to fearful faces, in accordance with previously reported results. Future studies should investigate whether exposure to psilocybin acutely changes emotion processing in individuals with depression and whether such changes are related to therapeutic outcomes.", "journal": "Neuroscience Applied", "publication_date": "2023-12-29", "publication_year": 2023, "doi": "10.1016/j.nsa.2023.103934", "pubmed_id": "40656071", "source_url": "https://doi.org/10.1016/j.nsa.2023.103934", "keywords": "Psilocybin, Amygdala, Psychology, Serotonergic, Functional magnetic resonance imaging, Hallucinogen, Reactivity (psychology), Neuroscience, Audiology, Serotonin, Medicine, Internal medicine, Psychiatry, Receptor, Pathology, Alternative medicine, Psychedelics and Drug Studies, Neurotransmitter Receptor Influence on Behavior, Forensic Toxicology and Drug Analysis", "substance_tags": "psilocybin,psilocin", "source_name": "OpenAlex", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4390452945\",\"openalex_url\":\"https://openalex.org/W4390452945\",\"openalex_relevance_score\":12,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"abstract:psilocybin\",\"metadata:psilocybin\",\"abstract:psilocin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":7,\"referenced_works\":[\"https://openalex.org/W1810655782\",\"https://openalex.org/W1937433122\",\"https://openalex.org/W1967996189\",\"https://openalex.org/W1974074998\",\"https://openalex.org/W1976863244\",\"https://openalex.org/W1981740630\",\"https://openalex.org/W1989982790\",\"https://openalex.org/W1997058647\",\"https://openalex.org/W1997927507\",\"https://openalex.org/W2001362807\",\"https://openalex.org/W2012626242\",\"https://openalex.org/W2022951276\",\"https://openalex.org/W2042593075\",\"https://openalex.org/W2043197532\",\"https://openalex.org/W2048416550\",\"https://openalex.org/W2048707777\",\"https://openalex.org/W2053497768\",\"https://openalex.org/W2053750947\",\"https://openalex.org/W2061554433\",\"https://openalex.org/W2075238613\",\"https://openalex.org/W2075969679\",\"https://openalex.org/W2093203605\",\"https://openalex.org/W2110431345\",\"https://openalex.org/W2113941552\",\"https://openalex.org/W2118492070\",\"https://openalex.org/W2118969780\",\"https://openalex.org/W2119134849\",\"https://openalex.org/W2121441663\",\"https://openalex.org/W2133194768\",\"https://openalex.org/W2151487996\",\"https://openalex.org/W2154105276\",\"https://openalex.org/W2158553737\",\"https://openalex.org/W2161555895\",\"https://openalex.org/W2165016477\",\"https://openalex.org/W2245231029\",\"https://openalex.org/W2341471783\",\"https://openalex.org/W2558412547\",\"https://openalex.org/W2559739670\",\"https://openalex.org/W2604586582\",\"https://openalex.org/W2624901555\",\"https://openalex.org/W2644260506\",\"https://openalex.org/W2781340150\",\"https://openalex.org/W2788854095\",\"https://openalex.org/W2792444257\",\"https://openalex.org/W2801890140\",\"https://openalex.org/W2805365294\",\"https://openalex.org/W2903001666\",\"https://openalex.org/W2914255920\",\"https://openalex.org/W2945506353\",\"https://openalex.org/W2959143276\",\"https://openalex.org/W2962285119\",\"https://openalex.org/W3009339612\",\"https://openalex.org/W3081047021\",\"https://openalex.org/W3085641834\",\"https://openalex.org/W3087859780\",\"https://openalex.org/W3091936754\",\"https://openalex.org/W3096208965\",\"https://openalex.org/W3118672806\",\"https://openalex.org/W3156937150\",\"https://openalex.org/W3164618783\",\"https://openalex.org/W3171418018\",\"https://openalex.org/W3179473685\",\"https://openalex.org/W4211211437\",\"https://openalex.org/W4213393122\",\"https://openalex.org/W4280491225\",\"https://openalex.org/W4292937262\",\"https://openalex.org/W6661503435\",\"https://openalex.org/W6676667350\",\"https://openalex.org/W6704359060\",\"https://openalex.org/W6765929559\",\"https://openalex.org/W6783748472\",\"https://openalex.org/W7074234824\"],\"authorships\":[{\"id\":\"https://openalex.org/A5086179765\",\"display_name\":\"Sophia Armand\",\"orcid\":\"https://orcid.org/0000-0001-6368-3329\"},{\"id\":\"https://openalex.org/A5027814368\",\"display_name\":\"Kristian Larsen\",\"orcid\":\"https://orcid.org/0000-0001-6835-0814\"},{\"id\":\"https://openalex.org/A5000203733\",\"display_name\":\"M. Madsen\",\"orcid\":\"https://orcid.org/0000-0001-8836-1844\"},{\"id\":\"https://openalex.org/A5021739634\",\"display_name\":\"Brice Ozenne\",\"orcid\":\"https://orcid.org/0000-0001-9694-2956\"},{\"id\":\"https://openalex.org/A5040977207\",\"display_name\":\"Katrin H. Preller\",\"orcid\":\"https://orcid.org/0000-0003-0413-7672\"},{\"id\":\"https://openalex.org/A5015895924\",\"display_name\":\"Gitte M. Knudsen\",\"orcid\":\"https://orcid.org/0000-0003-1508-6866\"},{\"id\":\"https://openalex.org/A5004791170\",\"display_name\":\"Dea Siggaard Stenbæk\",\"orcid\":\"https://orcid.org/0000-0002-5439-4637\"},{\"id\":\"https://openalex.org/A5021085020\",\"display_name\":\"Patrick M. Fisher\",\"orcid\":\"https://orcid.org/0000-0002-8115-0611\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2023.103934\",\"is_oa\":true}}", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Emotional Processing,Toxicity", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390452945" }, { "id": 4889, "title": "Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling", "normalized_title": "acute neurovascular effects of psilocybin administration in healthy humans implications for cerebral blood flow measurements using arterial spin labelling", "authors": "Klaus Richter Larsen, Ulrich Lindberg, Brice Ozenne, Drummond E-Wen McCulloch, Sophia Armand, M. Madsen, Annette Johansen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.102665", "pubmed_id": null, "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102665", "keywords": "Cerebral blood flow, Psilocybin, Neurovascular bundle, Arterial spin labeling, Medicine, Labelling, Anesthesia, Blood flow, Cardiology, Neuroscience, Pharmacology, Psychology, Hallucinogen, Pathology, Criminology, Psychedelics and Drug Studies, Neurotransmitter Receptor Influence on Behavior, Paranormal Experiences and Beliefs", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4390241281\",\"openalex_url\":\"https://openalex.org/W4390241281\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5029326001\",\"display_name\":\"Klaus Richter Larsen\",\"orcid\":\"https://orcid.org/0000-0003-2519-3454\"},{\"id\":\"https://openalex.org/A5022260648\",\"display_name\":\"Ulrich Lindberg\",\"orcid\":\"https://orcid.org/0000-0002-0004-6354\"},{\"id\":\"https://openalex.org/A5021739634\",\"display_name\":\"Brice Ozenne\",\"orcid\":\"https://orcid.org/0000-0001-9694-2956\"},{\"id\":\"https://openalex.org/A5064300685\",\"display_name\":\"Drummond E-Wen McCulloch\",\"orcid\":\"https://orcid.org/0000-0001-6360-5224\"},{\"id\":\"https://openalex.org/A5086179765\",\"display_name\":\"Sophia Armand\",\"orcid\":\"https://orcid.org/0000-0001-6368-3329\"},{\"id\":\"https://openalex.org/A5000203733\",\"display_name\":\"M. Madsen\",\"orcid\":\"https://orcid.org/0000-0001-8836-1844\"},{\"id\":\"https://openalex.org/A5072267838\",\"display_name\":\"Annette Johansen\",\"orcid\":\"https://orcid.org/0000-0003-0264-2368\"},{\"id\":\"https://openalex.org/A5004791170\",\"display_name\":\"Dea Siggaard Stenbæk\",\"orcid\":\"https://orcid.org/0000-0002-5439-4637\"},{\"id\":\"https://openalex.org/A5015895924\",\"display_name\":\"Gitte M. Knudsen\",\"orcid\":\"https://orcid.org/0000-0003-1508-6866\"},{\"id\":\"https://openalex.org/A5021085020\",\"display_name\":\"Patrick M. Fisher\",\"orcid\":\"https://orcid.org/0000-0002-8115-0611\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"http://dx.doi.org/10.1016/j.nsa.2023.102665\",\"is_oa\":true}}", "topic_tags": "Pharmacology,Receptor Pharmacology", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390241281" }, { "id": 4888, "title": "Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model", "normalized_title": "psilocybin rescues depressive phenotype and modulates serotonin 2a and glucocorticoid receptor mrna expression in brain cortex of a stress animal model", "authors": "Ines Erkizia-Santamaría, Guadalupe Rivero, Igor Horrillo, J. Javier Meana, Jorge E. Ortega", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.102452", "pubmed_id": null, "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102452", "keywords": "Glucocorticoid receptor, Psilocybin, Neuroscience, Phenotype, Glucocorticoid, Serotonin, Cortex (anatomy), Receptor, Endocrinology, Biology, Internal medicine, Hallucinogen, Medicine, Genetics, Pharmacology, Gene, Psychedelics and Drug Studies, Neurotransmitter Receptor Influence on Behavior, Nicotinic Acetylcholine Receptors Study", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4390223807\",\"openalex_url\":\"https://openalex.org/W4390223807\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5064629089\",\"display_name\":\"Ines Erkizia-Santamaría\",\"orcid\":\"https://orcid.org/0000-0002-6163-4571\"},{\"id\":\"https://openalex.org/A5066437036\",\"display_name\":\"Guadalupe Rivero\",\"orcid\":\"https://orcid.org/0000-0002-2537-4047\"},{\"id\":\"https://openalex.org/A5028869928\",\"display_name\":\"Igor Horrillo\",\"orcid\":\"https://orcid.org/0000-0003-0125-5884\"},{\"id\":\"https://openalex.org/A5024198476\",\"display_name\":\"J. Javier Meana\",\"orcid\":\"https://orcid.org/0000-0002-7913-6714\"},{\"id\":\"https://openalex.org/A5033481973\",\"display_name\":\"Jorge E. Ortega\",\"orcid\":\"https://orcid.org/0000-0001-8188-874X\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"http://dx.doi.org/10.1016/j.nsa.2023.102452\",\"is_oa\":true}}", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390223807" }, { "id": 4887, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study", "normalized_title": "the safety and efficacy of comp360 psilocybin therapy in treatment resistant depression results from a long term observational follow up study", "authors": "Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons, E.K. Teoh, Jeng-Yu Tsai, E. Malievskaia", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.102906", "pubmed_id": null, "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102906", "keywords": "Psilocybin, Observational study, Depression (economics), Term (time), Medicine, Psychiatry, Psychology, Hallucinogen, Psychotherapist, Internal medicine, Physics, Economics, Macroeconomics, Quantum mechanics, Psychedelics and Drug Studies, Digital Mental Health Interventions, Mental Health and Psychiatry", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4390223380\",\"openalex_url\":\"https://openalex.org/W4390223380\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"compound:comp360\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5037628078\",\"display_name\":\"Guy M. Goodwin\",\"orcid\":\"https://orcid.org/0000-0002-1426-2816\"},{\"id\":\"https://openalex.org/A5080462431\",\"display_name\":\"Lindsey Marwood\",\"orcid\":\"https://orcid.org/0000-0002-5818-2199\"},{\"id\":\"https://openalex.org/A5016967968\",\"display_name\":\"S. Mistry\",\"orcid\":null},{\"id\":\"https://openalex.org/A5036831540\",\"display_name\":\"Anna Nowakowska\",\"orcid\":\"https://orcid.org/0000-0003-4016-1522\"},{\"id\":\"https://openalex.org/A5076970739\",\"display_name\":\"Zainib Shabir\",\"orcid\":\"https://orcid.org/0000-0002-1865-7241\"},{\"id\":\"https://openalex.org/A5110391116\",\"display_name\":\"H. Clifton Simmons\",\"orcid\":\"https://orcid.org/0009-0000-5738-5771\"},{\"id\":\"https://openalex.org/A5111628063\",\"display_name\":\"E.K. Teoh\",\"orcid\":null},{\"id\":\"https://openalex.org/A5008221825\",\"display_name\":\"Jeng-Yu Tsai\",\"orcid\":\"https://orcid.org/0000-0002-8657-3744\"},{\"id\":\"https://openalex.org/A5012063316\",\"display_name\":\"E. Malievskaia\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"http://dx.doi.org/10.1016/j.nsa.2023.102906\",\"is_oa\":true}}", "topic_tags": "Depression,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390223380" }, { "id": 4886, "title": "Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression", "normalized_title": "effect of co administration of low doses of psilocybin and mglur2 3 antagonist ly341495 in chronic restraint stress model of depression", "authors": "Agata Machaczka, Jane Turek, Dorota Bederska-Łojewska, Bartłomiej Pochwat, Łukasz Gąsior, Bernadeta Szewczyk, Andrzej Pilc", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.102939", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2023.102939", "keywords": "Psilocybin, Antagonist, Depression (economics), Psychology, Medicine, Psychiatry, Internal medicine, Hallucinogen, Receptor, Economics, Macroeconomics, Psychedelics and Drug Studies, Chemical synthesis and alkaloids, Treatment of Major Depression", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4390223307\",\"openalex_url\":\"https://openalex.org/W4390223307\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5046125337\",\"display_name\":\"Agata Machaczka\",\"orcid\":\"https://orcid.org/0000-0001-6378-4795\"},{\"id\":\"https://openalex.org/A5111100401\",\"display_name\":\"Jane Turek\",\"orcid\":null},{\"id\":\"https://openalex.org/A5068240095\",\"display_name\":\"Dorota Bederska-Łojewska\",\"orcid\":\"https://orcid.org/0000-0002-9958-3730\"},{\"id\":\"https://openalex.org/A5028212666\",\"display_name\":\"Bartłomiej Pochwat\",\"orcid\":\"https://orcid.org/0000-0002-3785-6721\"},{\"id\":\"https://openalex.org/A5037111048\",\"display_name\":\"Łukasz Gąsior\",\"orcid\":\"https://orcid.org/0000-0001-6417-9861\"},{\"id\":\"https://openalex.org/A5045678056\",\"display_name\":\"Bernadeta Szewczyk\",\"orcid\":\"https://orcid.org/0000-0002-6863-7951\"},{\"id\":\"https://openalex.org/A5082517862\",\"display_name\":\"Andrzej Pilc\",\"orcid\":\"https://orcid.org/0000-0002-4045-0597\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2023.102939\",\"is_oa\":true}}", "topic_tags": "Depression,Receptor Pharmacology", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390223307" }, { "id": 4885, "title": "Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice", "normalized_title": "behavioral effects of a 14 day repeated treatment with psilocybin at a low non psychedelic dose a preliminary study in c57bl 6j mice", "authors": "Sofia Nasini, Martina Colognesi, Sara Tidei, Sara De Martin, Marco Banzato, Andrea Mattarei, Franco Folli, P. Marco, Paolo L. Manfredi, Stefano Comai", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.103378", "pubmed_id": null, "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103378", "keywords": "Psilocybin, Psychology, Hallucinogen, Scratching, Wheel running, Pharmacology, Medicine, Psychiatry, Internal medicine, Physics, Acoustics, Psychedelics and Drug Studies, Neurotransmitter Receptor Influence on Behavior, Biochemical Analysis and Sensing Techniques", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4390222334\",\"openalex_url\":\"https://openalex.org/W4390222334\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5068542698\",\"display_name\":\"Sofia Nasini\",\"orcid\":\"https://orcid.org/0000-0002-5821-9684\"},{\"id\":\"https://openalex.org/A5060460268\",\"display_name\":\"Martina Colognesi\",\"orcid\":\"https://orcid.org/0009-0000-7839-7851\"},{\"id\":\"https://openalex.org/A5092171055\",\"display_name\":\"Sara Tidei\",\"orcid\":null},{\"id\":\"https://openalex.org/A5059921142\",\"display_name\":\"Sara De Martin\",\"orcid\":\"https://orcid.org/0000-0001-6398-8237\"},{\"id\":\"https://openalex.org/A5093581998\",\"display_name\":\"Marco Banzato\",\"orcid\":null},{\"id\":\"https://openalex.org/A5065244580\",\"display_name\":\"Andrea Mattarei\",\"orcid\":\"https://orcid.org/0000-0002-2023-0749\"},{\"id\":\"https://openalex.org/A5053802958\",\"display_name\":\"Franco Folli\",\"orcid\":\"https://orcid.org/0000-0001-9824-5222\"},{\"id\":null,\"display_name\":\"P. Marco\",\"orcid\":null},{\"id\":\"https://openalex.org/A5004302186\",\"display_name\":\"Paolo L. Manfredi\",\"orcid\":\"https://orcid.org/0000-0002-7242-9450\"},{\"id\":\"https://openalex.org/A5018646315\",\"display_name\":\"Stefano Comai\",\"orcid\":\"https://orcid.org/0000-0002-5686-7194\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"http://dx.doi.org/10.1016/j.nsa.2023.103378\",\"is_oa\":true}}", "topic_tags": "Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390222334" }, { "id": 4884, "title": "Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial", "normalized_title": "withdrawal of antidepressants does not impact the efficacy of comp360 psilocybin therapy results from a phase iib randomised controlled trial", "authors": "Guy M. Goodwin, Megan Croal, J. Chai-Rees, Lindsey Marwood, S. Mistry, Anna Nowakowska, H. Clifton Simmons, Jeng-Yu Tsai", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.103487", "pubmed_id": null, "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103487", "keywords": "Psilocybin, Medicine, Internal medicine, Psychiatry, Hallucinogen, Psychedelics and Drug Studies, Mental Health and Psychiatry, Digital Mental Health Interventions", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4390222321\",\"openalex_url\":\"https://openalex.org/W4390222321\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"compound:comp360\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5037628078\",\"display_name\":\"Guy M. Goodwin\",\"orcid\":\"https://orcid.org/0000-0002-1426-2816\"},{\"id\":\"https://openalex.org/A5072218538\",\"display_name\":\"Megan Croal\",\"orcid\":\"https://orcid.org/0000-0002-3286-1003\"},{\"id\":\"https://openalex.org/A5093581995\",\"display_name\":\"J. Chai-Rees\",\"orcid\":null},{\"id\":\"https://openalex.org/A5080462431\",\"display_name\":\"Lindsey Marwood\",\"orcid\":\"https://orcid.org/0000-0002-5818-2199\"},{\"id\":\"https://openalex.org/A5108394445\",\"display_name\":\"S. Mistry\",\"orcid\":null},{\"id\":\"https://openalex.org/A5036831540\",\"display_name\":\"Anna Nowakowska\",\"orcid\":\"https://orcid.org/0000-0003-4016-1522\"},{\"id\":\"https://openalex.org/A5110391116\",\"display_name\":\"H. Clifton Simmons\",\"orcid\":\"https://orcid.org/0009-0000-5738-5771\"},{\"id\":\"https://openalex.org/A5008221825\",\"display_name\":\"Jeng-Yu Tsai\",\"orcid\":\"https://orcid.org/0000-0002-8657-3744\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"http://dx.doi.org/10.1016/j.nsa.2023.103487\",\"is_oa\":true}}", "topic_tags": "Clinical Trial,Randomized Controlled Trial", "study_type": "Randomized Controlled Trial", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390222321" }, { "id": 4883, "title": "Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls", "normalized_title": "change in whole blood bdnf after escitalopram or psilocybin intervention in patients with depression and healthy controls", "authors": "Miriam L. Navarro, Alberte Wollesen Breum, Annette Johansen, Brice Ozenne, Vibe G. Frøkjær, Gitte M. Knudsen", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.103646", "pubmed_id": null, "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103646", "keywords": "Escitalopram, Psilocybin, Depression (economics), Psychology, Medicine, Psychiatry, Intervention (counseling), Clinical psychology, Internal medicine, Anxiety, Antidepressant, Hallucinogen, Macroeconomics, Economics, Psychedelics and Drug Studies, Personality Disorders and Psychopathology, Mental Health Research Topics", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4390222237\",\"openalex_url\":\"https://openalex.org/W4390222237\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5104219911\",\"display_name\":\"Miriam L. Navarro\",\"orcid\":null},{\"id\":\"https://openalex.org/A5045533041\",\"display_name\":\"Alberte Wollesen Breum\",\"orcid\":\"https://orcid.org/0000-0002-8399-4308\"},{\"id\":\"https://openalex.org/A5072267838\",\"display_name\":\"Annette Johansen\",\"orcid\":\"https://orcid.org/0000-0003-0264-2368\"},{\"id\":\"https://openalex.org/A5021739634\",\"display_name\":\"Brice Ozenne\",\"orcid\":\"https://orcid.org/0000-0001-9694-2956\"},{\"id\":\"https://openalex.org/A5029788021\",\"display_name\":\"Vibe G. Frøkjær\",\"orcid\":\"https://orcid.org/0000-0002-9321-2365\"},{\"id\":\"https://openalex.org/A5015895924\",\"display_name\":\"Gitte M. Knudsen\",\"orcid\":\"https://orcid.org/0000-0003-1508-6866\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"http://dx.doi.org/10.1016/j.nsa.2023.103646\",\"is_oa\":true}}", "topic_tags": "Depression,Anxiety,Personality Change", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390222237" }, { "id": 4882, "title": "A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteers", "normalized_title": "a multi metric evaluation of psilocybin effects on functional brain entropy in healthy volunteers", "authors": "Drummond E-Wen McCulloch, Anders Smærup Olsen, Dea Siggaard Stenbæk, Sophia Armand, M. Madsen, Gitte M. Knudsen, Patrick M. Fisher", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.103723", "pubmed_id": null, "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103723", "keywords": "Psilocybin, Psychology, Metric (unit), Hallucinogen, Neuroscience, Cognitive psychology, Psychiatry, Business, Marketing, Psychedelics and Drug Studies, Paranormal Experiences and Beliefs, Digital Mental Health Interventions", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4390222176\",\"openalex_url\":\"https://openalex.org/W4390222176\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5064300685\",\"display_name\":\"Drummond E-Wen McCulloch\",\"orcid\":\"https://orcid.org/0000-0001-6360-5224\"},{\"id\":\"https://openalex.org/A5086988891\",\"display_name\":\"Anders Smærup Olsen\",\"orcid\":\"https://orcid.org/0000-0001-8589-1436\"},{\"id\":\"https://openalex.org/A5004791170\",\"display_name\":\"Dea Siggaard Stenbæk\",\"orcid\":\"https://orcid.org/0000-0002-5439-4637\"},{\"id\":\"https://openalex.org/A5086179765\",\"display_name\":\"Sophia Armand\",\"orcid\":\"https://orcid.org/0000-0001-6368-3329\"},{\"id\":\"https://openalex.org/A5000203733\",\"display_name\":\"M. Madsen\",\"orcid\":\"https://orcid.org/0000-0001-8836-1844\"},{\"id\":\"https://openalex.org/A5015895924\",\"display_name\":\"Gitte M. Knudsen\",\"orcid\":\"https://orcid.org/0000-0003-1508-6866\"},{\"id\":\"https://openalex.org/A5021085020\",\"display_name\":\"Patrick M. Fisher\",\"orcid\":\"https://orcid.org/0000-0002-8115-0611\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"http://dx.doi.org/10.1016/j.nsa.2023.103723\",\"is_oa\":true}}", "topic_tags": "Healthy Volunteers", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390222176" }, { "id": 4881, "title": "Investigating changes in EEG entropy rate in response to psilocybin - a comparison of lempel ziv and state-space entropy rate measures", "normalized_title": "investigating changes in eeg entropy rate in response to psilocybin a comparison of lempel ziv and state space entropy rate measures", "authors": "M. Nikolič, P. Mediano, Tom Froese, Tomáš Páleníček", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.103667", "pubmed_id": null, "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.103667", "keywords": "Psilocybin, Electroencephalography, Entropy (arrow of time), Mathematics, Statistical physics, Psychology, Statistics, Physics, Neuroscience, Thermodynamics, Hallucinogen, Psychiatry, Psychedelics and Drug Studies, Mental Health Research Topics, Digital Mental Health Interventions", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4390222110\",\"openalex_url\":\"https://openalex.org/W4390222110\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5010574775\",\"display_name\":\"M. Nikolič\",\"orcid\":\"https://orcid.org/0000-0002-2564-7287\"},{\"id\":\"https://openalex.org/A5067129421\",\"display_name\":\"P. Mediano\",\"orcid\":null},{\"id\":\"https://openalex.org/A5041658140\",\"display_name\":\"Tom Froese\",\"orcid\":\"https://orcid.org/0000-0002-9899-5274\"},{\"id\":\"https://openalex.org/A5056888000\",\"display_name\":\"Tomáš Páleníček\",\"orcid\":\"https://orcid.org/0000-0002-3109-9539\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"http://dx.doi.org/10.1016/j.nsa.2023.103667\",\"is_oa\":true}}", "topic_tags": "Brain Imaging", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390222110" }, { "id": 4876, "title": "Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders.", "normalized_title": "therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders", "authors": "O. Shahar, A. Botvinik, T. Lifschytz, B. Lerer", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.101067", "pubmed_id": null, "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.101067", "keywords": "Psilocybin, Depression (economics), Mechanism (biology), Psychiatry, Psychology, Hallucinogen, Medicine, Psychotherapist, Philosophy, Economics, Epistemology, Macroeconomics, Psychedelics and Drug Studies", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4327497830\",\"openalex_url\":\"https://openalex.org/W4327497830\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5047369776\",\"display_name\":\"O. Shahar\",\"orcid\":null},{\"id\":\"https://openalex.org/A5016497054\",\"display_name\":\"A. Botvinik\",\"orcid\":null},{\"id\":\"https://openalex.org/A5007000691\",\"display_name\":\"T. Lifschytz\",\"orcid\":null},{\"id\":\"https://openalex.org/A5066118844\",\"display_name\":\"B. Lerer\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"http://dx.doi.org/10.1016/j.nsa.2023.101067\",\"is_oa\":true}}", "topic_tags": "Depression", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4327497830" }, { "id": 4866, "title": "Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results", "normalized_title": "psilocybin as a treatment for anorexia nervosa 6 week and 3 month follow up results", "authors": "Hannah Douglass, Merle Spriggs, Kate Godfrey, Jennifer L. Danby, Francisco Magalhães, Kirsty L. Alderton, Liane Macdonald, Stephanie Archer, Tim Read, Adèle Lafrance, Dasha Nicholls, David Erritzøe, R. Park, David Nutt, Robin Carhart-Harris", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.102878", "pubmed_id": null, "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102878", "keywords": "Psilocybin, Anorexia nervosa, Anorexia, Psychiatry, Psychology, Medicine, Psychotherapist, Hallucinogen, Eating disorders, Internal medicine, Psychedelics and Drug Studies, Sexuality, Behavior, and Technology, Digital Mental Health Interventions", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4390223843\",\"openalex_url\":\"https://openalex.org/W4390223843\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":1,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5031966441\",\"display_name\":\"Hannah Douglass\",\"orcid\":\"https://orcid.org/0000-0002-4033-385X\"},{\"id\":\"https://openalex.org/A5009572967\",\"display_name\":\"Merle Spriggs\",\"orcid\":\"https://orcid.org/0000-0002-0432-2854\"},{\"id\":\"https://openalex.org/A5056222921\",\"display_name\":\"Kate Godfrey\",\"orcid\":\"https://orcid.org/0000-0002-2578-2382\"},{\"id\":\"https://openalex.org/A5046578118\",\"display_name\":\"Jennifer L. Danby\",\"orcid\":null},{\"id\":\"https://openalex.org/A5018245067\",\"display_name\":\"Francisco Magalhães\",\"orcid\":\"https://orcid.org/0000-0002-8542-4245\"},{\"id\":\"https://openalex.org/A5008058826\",\"display_name\":\"Kirsty L. Alderton\",\"orcid\":null},{\"id\":\"https://openalex.org/A5109167719\",\"display_name\":\"Liane Macdonald\",\"orcid\":\"https://orcid.org/0000-0001-8674-4286\"},{\"id\":\"https://openalex.org/A5087738625\",\"display_name\":\"Stephanie Archer\",\"orcid\":\"https://orcid.org/0000-0003-1349-7178\"},{\"id\":\"https://openalex.org/A5083068952\",\"display_name\":\"Tim Read\",\"orcid\":\"https://orcid.org/0000-0002-9755-4848\"},{\"id\":\"https://openalex.org/A5035542356\",\"display_name\":\"Adèle Lafrance\",\"orcid\":\"https://orcid.org/0000-0002-4935-7786\"},{\"id\":\"https://openalex.org/A5030053635\",\"display_name\":\"Dasha Nicholls\",\"orcid\":\"https://orcid.org/0000-0001-7257-6605\"},{\"id\":\"https://openalex.org/A5044907549\",\"display_name\":\"David Erritzøe\",\"orcid\":\"https://orcid.org/0000-0002-7022-6211\"},{\"id\":\"https://openalex.org/A5015978478\",\"display_name\":\"R. Park\",\"orcid\":null},{\"id\":\"https://openalex.org/A5016082897\",\"display_name\":\"David Nutt\",\"orcid\":\"https://orcid.org/0000-0002-1286-1401\"},{\"id\":\"https://openalex.org/A5038609897\",\"display_name\":\"Robin Carhart-Harris\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"http://dx.doi.org/10.1016/j.nsa.2023.102878\",\"is_oa\":true}}", "topic_tags": "Eating Disorders", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390223843" }, { "id": 2014, "title": "Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvement", "normalized_title": "electrophysiological study of visual and auditory processing in psilocin induced hallucinations exploring evoked potentials and 5 ht2a receptor involvement", "authors": "Vejmola Č., Hubený J., Koudelka V., Griškova-Bulanova I., Páleníček T.", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.103662", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2023.103662", "keywords": "", "substance_tags": "psilocin", "source_name": "Crossref", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-01 11:21:33", "raw_json": "{\"doi\":\"10.1016/j.nsa.2023.103662\",\"reference_dois\":[],\"reference_count\":0}", "topic_tags": "Receptor Pharmacology", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4390222133" }, { "id": 1811, "title": "Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.", "normalized_title": "methodological challenges in psychedelic drug trials efficacy and safety of psilocybin in treatment resistant major depression episode rationale and study design", "authors": "Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G.", "abstract": "Psychedelics such as psilocybin have recently gained remarkable interest in both the specialist literature and the lay press because studies suggest that these substances may have great therapeutic potential in various psychiatric disorders, including major depression. However, clinical trials with psychedelic drugs pose particular methodological challenges to researchers, some of which differ considerably from those with other psychotropic drugs. These include the problem of successful blinding, which can hardly be guaranteed in clinical trials with psychedelic substances and - directly related - the high risk of expectation bias and nocebo effects. Some of these challenges are being addressed in the given clinical trial on the efficacy and safety of psilocybin in treatment-resistant major depression. It is a phase II randomized, double-blind, active placebo-controlled parallel group trial with 144 patients. The rationale, the study design, and the core features of the study are presented here. The trial (EPIsoDE trial; EudraCT number: 2019-003984-24; NCT04670081) is funded by the German Federal Ministry of Education and Research (BMBF 01EN2006 ​A/B).", "journal": "Neuroscience Applied", "publication_date": "2022-03-06", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100104", "pubmed_id": "40656230", "source_url": "https://doi.org/10.1016/j.nsa.2022.100104", "keywords": "", "substance_tags": "psilocybin", "source_name": "Europe PMC", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"europe_pmc_id\":\"40656230\",\"source\":\"MED\",\"pub_type\":null,\"publisher\":null,\"importer\":\"Europe PMC\",\"openalex_enrichment\":{\"openalex_id\":\"https://openalex.org/W4220708535\",\"openalex_url\":\"https://openalex.org/W4220708535\",\"openalex_relevance_score\":9,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"abstract:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":40,\"referenced_works\":[\"https://openalex.org/W1655045766\",\"https://openalex.org/W1776258049\",\"https://openalex.org/W1948877773\",\"https://openalex.org/W1970054184\",\"https://openalex.org/W1992844800\",\"https://openalex.org/W2001101493\",\"https://openalex.org/W2009122980\",\"https://openalex.org/W2022191212\",\"https://openalex.org/W2043530175\",\"https://openalex.org/W2047503435\",\"https://openalex.org/W2056438596\",\"https://openalex.org/W2072833030\",\"https://openalex.org/W2075238613\",\"https://openalex.org/W2121441663\",\"https://openalex.org/W2127662631\",\"https://openalex.org/W2152472333\",\"https://openalex.org/W2164182651\",\"https://openalex.org/W2164198137\",\"https://openalex.org/W2167987245\",\"https://openalex.org/W2253040643\",\"https://openalex.org/W2277633149\",\"https://openalex.org/W2330686105\",\"https://openalex.org/W2396675581\",\"https://openalex.org/W2404687886\",\"https://openalex.org/W2506717582\",\"https://openalex.org/W2549202270\",\"https://openalex.org/W2558412547\",\"https://openalex.org/W2559739670\",\"https://openalex.org/W2779386549\",\"https://openalex.org/W2781316183\",\"https://openalex.org/W2784069100\",\"https://openalex.org/W2788337440\",\"https://openalex.org/W2791088784\",\"https://openalex.org/W2792444257\",\"https://openalex.org/W2799742551\",\"https://openalex.org/W2806188084\",\"https://openalex.org/W2895197076\",\"https://openalex.org/W2948548704\",\"https://openalex.org/W2962285119\",\"https://openalex.org/W2970458256\",\"https://openalex.org/W2974814938\",\"https://openalex.org/W3096208965\",\"https://openalex.org/W3112535936\",\"https://openalex.org/W3124059976\",\"https://openalex.org/W3156937150\",\"https://openalex.org/W3162909048\",\"https://openalex.org/W3164618783\",\"https://openalex.org/W3177300439\",\"https://openalex.org/W3193440797\",\"https://openalex.org/W4288077072\",\"https://openalex.org/W6695084235\",\"https://openalex.org/W6755541052\",\"https://openalex.org/W6818643326\"],\"authorships\":[{\"id\":\"https://openalex.org/A5070309082\",\"display_name\":\"Lea J. Mertens\",\"orcid\":\"https://orcid.org/0000-0003-4415-3941\"},{\"id\":\"https://openalex.org/A5045306689\",\"display_name\":\"Michael Koslowski\",\"orcid\":\"https://orcid.org/0000-0001-8798-9875\"},{\"id\":\"https://openalex.org/A5031618523\",\"display_name\":\"Felix Betzler\",\"orcid\":\"https://orcid.org/0000-0002-1389-4870\"},{\"id\":\"https://openalex.org/A5054444045\",\"display_name\":\"Ricarda Evens\",\"orcid\":\"https://orcid.org/0000-0002-2834-2171\"},{\"id\":\"https://openalex.org/A5015683895\",\"display_name\":\"Maria Gilles\",\"orcid\":\"https://orcid.org/0000-0002-9604-4459\"},{\"id\":\"https://openalex.org/A5016321877\",\"display_name\":\"Andrea Jungaberle\",\"orcid\":null},{\"id\":\"https://openalex.org/A5001710309\",\"display_name\":\"Henrik Jungaberle\",\"orcid\":\"https://orcid.org/0000-0001-7634-4211\"},{\"id\":\"https://openalex.org/A5065637165\",\"display_name\":\"Tomislav Majić\",\"orcid\":\"https://orcid.org/0000-0003-2950-6673\"},{\"id\":\"https://openalex.org/A5066612577\",\"display_name\":\"Andreas Ströhle\",\"orcid\":\"https://orcid.org/0000-0003-0935-3702\"},{\"id\":\"https://openalex.org/A5075794355\",\"display_name\":\"Max Wolff\",\"orcid\":\"https://orcid.org/0000-0001-6896-9633\"},{\"id\":\"https://openalex.org/A5063934463\",\"display_name\":\"Stefan Wellek\",\"orcid\":\"https://orcid.org/0000-0001-8369-8122\"},{\"id\":\"https://openalex.org/A5081339058\",\"display_name\":\"Gerhard Gründer\",\"orcid\":\"https://orcid.org/0000-0001-7868-3903\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100104\",\"is_oa\":true}}}", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4220708535" }, { "id": 5024, "title": "Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans", "normalized_title": "acute psilocybin and ketanserin effects on cerebral blood flow 5 ht2ar neuromodulatory effects in healthy humans", "authors": "Klaus Richter Larsen, Drummond E-Wen McCulloch, Brice Ozenne, Ulrich Lindberg, Sophia Armand, M. Madsen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100335", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100335", "keywords": "Ketanserin, Cerebral blood flow, Psilocybin, Medicine, Hallucinogen, Blood flow, Anesthesia, Neuroscience, Psychology, Cardiology, Pharmacology, Internal medicine, Serotonin, 5-HT receptor, Receptor, Psychedelics and Drug Studies, Neurotransmitter Receptor Influence on Behavior, Chemical synthesis and alkaloids", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4313201140\",\"openalex_url\":\"https://openalex.org/W4313201140\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5029326001\",\"display_name\":\"Klaus Richter Larsen\",\"orcid\":\"https://orcid.org/0000-0003-2519-3454\"},{\"id\":\"https://openalex.org/A5064300685\",\"display_name\":\"Drummond E-Wen McCulloch\",\"orcid\":\"https://orcid.org/0000-0001-6360-5224\"},{\"id\":\"https://openalex.org/A5021739634\",\"display_name\":\"Brice Ozenne\",\"orcid\":\"https://orcid.org/0000-0001-9694-2956\"},{\"id\":\"https://openalex.org/A5022260648\",\"display_name\":\"Ulrich Lindberg\",\"orcid\":\"https://orcid.org/0000-0002-0004-6354\"},{\"id\":\"https://openalex.org/A5086179765\",\"display_name\":\"Sophia Armand\",\"orcid\":\"https://orcid.org/0000-0001-6368-3329\"},{\"id\":\"https://openalex.org/A5000203733\",\"display_name\":\"M. Madsen\",\"orcid\":\"https://orcid.org/0000-0001-8836-1844\"},{\"id\":\"https://openalex.org/A5004791170\",\"display_name\":\"Dea Siggaard Stenbæk\",\"orcid\":\"https://orcid.org/0000-0002-5439-4637\"},{\"id\":\"https://openalex.org/A5015895924\",\"display_name\":\"Gitte M. Knudsen\",\"orcid\":\"https://orcid.org/0000-0003-1508-6866\"},{\"id\":\"https://openalex.org/A5021085020\",\"display_name\":\"Patrick M. Fisher\",\"orcid\":\"https://orcid.org/0000-0002-8115-0611\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100335\",\"is_oa\":true}}", "topic_tags": "Pharmacology,Receptor Pharmacology", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313201140" }, { "id": 5023, "title": "Neurochemical properties of psilocybin in comparison to ketamine in vivo", "normalized_title": "neurochemical properties of psilocybin in comparison to ketamine in vivo", "authors": "A. Wojtas, A. Bysiek, Z. Szych, M. Herian, K. Gołembiowska", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100408", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100408", "keywords": "Psilocybin, Neurochemical, Ketamine, In vivo, Neuroscience, Hallucinogen, Psychology, Pharmacology, Medicine, Biology, Biotechnology, Psychedelics and Drug Studies, Treatment of Major Depression, Neurotransmitter Receptor Influence on Behavior", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4313201121\",\"openalex_url\":\"https://openalex.org/W4313201121\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5012206995\",\"display_name\":\"A. Wojtas\",\"orcid\":null},{\"id\":\"https://openalex.org/A5065633559\",\"display_name\":\"A. Bysiek\",\"orcid\":null},{\"id\":\"https://openalex.org/A5085358436\",\"display_name\":\"Z. Szych\",\"orcid\":null},{\"id\":\"https://openalex.org/A5075525050\",\"display_name\":\"M. Herian\",\"orcid\":null},{\"id\":\"https://openalex.org/A5049363185\",\"display_name\":\"K. Gołembiowska\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100408\",\"is_oa\":true}}", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313201121" }, { "id": 5022, "title": "Differential effects of repeated treatment with DOI and psilocybin on the head-twitch response (HTR), locomotor activity and anxiety-like behaviour", "normalized_title": "differential effects of repeated treatment with doi and psilocybin on the head twitch response htr locomotor activity and anxiety like behaviour", "authors": "E. Stojek, Jack Prenderville, F. Dunphy-Doherty", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100764", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100764", "keywords": "Psilocybin, Anxiety, Differential effects, Psychology, Neuroscience, Head (geology), Hallucinogen, Medicine, Psychiatry, Internal medicine, Biology, Paleontology, Psychedelics and Drug Studies, Mental Health and Psychiatry, Psychotherapy Techniques and Applications", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4313200992\",\"openalex_url\":\"https://openalex.org/W4313200992\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5001419772\",\"display_name\":\"E. Stojek\",\"orcid\":null},{\"id\":\"https://openalex.org/A5090856901\",\"display_name\":\"Jack Prenderville\",\"orcid\":null},{\"id\":\"https://openalex.org/A5036269753\",\"display_name\":\"F. Dunphy-Doherty\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100764\",\"is_oa\":true}}", "topic_tags": "Anxiety", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313200992" }, { "id": 5021, "title": "Effects of psilocybin in relative and global cerebral blood flow and behavioural correlates", "normalized_title": "effects of psilocybin in relative and global cerebral blood flow and behavioural correlates", "authors": "Nathalie M. Rieser, Ladina P Gubser, Franz X. Vollenweider, Meyer Lars, Katrin H. Preller", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100702", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100702", "keywords": "Psilocybin, Cerebral blood flow, Psychology, Hallucinogen, Neuroscience, Cognitive psychology, Medicine, Anesthesia, Psychiatry, Psychedelics and Drug Studies, Paranormal Experiences and Beliefs, Mental Health and Psychiatry", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4313200870\",\"openalex_url\":\"https://openalex.org/W4313200870\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5050105328\",\"display_name\":\"Nathalie M. Rieser\",\"orcid\":\"https://orcid.org/0000-0002-5804-1409\"},{\"id\":\"https://openalex.org/A5055186073\",\"display_name\":\"Ladina P Gubser\",\"orcid\":null},{\"id\":\"https://openalex.org/A5086283052\",\"display_name\":\"Franz X. Vollenweider\",\"orcid\":\"https://orcid.org/0000-0001-9053-6164\"},{\"id\":\"https://openalex.org/A5068447650\",\"display_name\":\"Meyer Lars\",\"orcid\":null},{\"id\":\"https://openalex.org/A5040977207\",\"display_name\":\"Katrin H. Preller\",\"orcid\":\"https://orcid.org/0000-0003-0413-7672\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100702\",\"is_oa\":true}}", "topic_tags": "General", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313200870" }, { "id": 5020, "title": "Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in mice", "normalized_title": "neurochemical and behavioural characterisation of the psychedelic 5ht2ar agonist psilocybin in mice", "authors": "Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, Albert Adell, J. Javier Meana, J.E. Ortega", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100407", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100407", "keywords": "Psilocybin, Neurochemical, Hallucinogen, Agonist, Psychology, Neuroscience, Pharmacology, Medicine, Psychiatry, Internal medicine, Receptor, Psychedelics and Drug Studies, Neurotransmitter Receptor Influence on Behavior, Chemical synthesis and alkaloids", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4313200261\",\"openalex_url\":\"https://openalex.org/W4313200261\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5064629089\",\"display_name\":\"Ines Erkizia-Santamaría\",\"orcid\":\"https://orcid.org/0000-0002-6163-4571\"},{\"id\":\"https://openalex.org/A5007763947\",\"display_name\":\"R. Alles-Pascual\",\"orcid\":null},{\"id\":\"https://openalex.org/A5028869928\",\"display_name\":\"Igor Horrillo\",\"orcid\":\"https://orcid.org/0000-0003-0125-5884\"},{\"id\":\"https://openalex.org/A5045533329\",\"display_name\":\"Albert Adell\",\"orcid\":\"https://orcid.org/0000-0003-0570-4931\"},{\"id\":\"https://openalex.org/A5024198476\",\"display_name\":\"J. Javier Meana\",\"orcid\":\"https://orcid.org/0000-0002-7913-6714\"},{\"id\":\"https://openalex.org/A5105369889\",\"display_name\":\"J.E. Ortega\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100407\",\"is_oa\":true}}", "topic_tags": "Pharmacology,Receptor Pharmacology,Animal Study", "study_type": "Animal Study", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313200261" }, { "id": 5019, "title": "The effect of psilocybin and sleep manipulation on neuroplasticity and sleep architecture in rats", "normalized_title": "the effect of psilocybin and sleep manipulation on neuroplasticity and sleep architecture in rats", "authors": "Lucie Olejníková, Klára Šíchová, K. Chona, Hynek Danda, Tomáš Páleníček", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100948", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100948", "keywords": "Psilocybin, Neuroplasticity, Sleep (system call), Sleep architecture, Psychology, Neuroscience, Electroencephalography, Psychiatry, Computer science, Polysomnography, Hallucinogen, Operating system, Psychedelics and Drug Studies, Sleep and Wakefulness Research, Cannabis and Cannabinoid Research", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4313199668\",\"openalex_url\":\"https://openalex.org/W4313199668\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5008280882\",\"display_name\":\"Lucie Olejníková\",\"orcid\":\"https://orcid.org/0000-0002-5313-3806\"},{\"id\":\"https://openalex.org/A5002474987\",\"display_name\":\"Klára Šíchová\",\"orcid\":\"https://orcid.org/0000-0003-1653-822X\"},{\"id\":\"https://openalex.org/A5011990805\",\"display_name\":\"K. Chona\",\"orcid\":null},{\"id\":\"https://openalex.org/A5073691780\",\"display_name\":\"Hynek Danda\",\"orcid\":\"https://orcid.org/0000-0003-4342-3268\"},{\"id\":\"https://openalex.org/A5056888000\",\"display_name\":\"Tomáš Páleníček\",\"orcid\":\"https://orcid.org/0000-0002-3109-9539\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100948\",\"is_oa\":true}}", "topic_tags": "Neuroplasticity", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313199668" }, { "id": 5018, "title": "The role of psilocybin in memory consolidation in the animal model", "normalized_title": "the role of psilocybin in memory consolidation in the animal model", "authors": "K. Šíchová, K. Chona, Lucie Olejníková Ladislavová, T. Páleníček", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100953", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100953", "keywords": "Psilocybin, Consolidation (business), Animal model, Memory consolidation, Psychology, Cognitive psychology, Hallucinogen, Neuroscience, Biology, Business, Psychiatry, Hippocampus, Accounting, Endocrinology, Psychedelics and Drug Studies, Chemical synthesis and alkaloids", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4313199409\",\"openalex_url\":\"https://openalex.org/W4313199409\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5018306841\",\"display_name\":\"K. Šíchová\",\"orcid\":null},{\"id\":\"https://openalex.org/A5011990805\",\"display_name\":\"K. Chona\",\"orcid\":null},{\"id\":\"https://openalex.org/A5047861297\",\"display_name\":\"Lucie Olejníková Ladislavová\",\"orcid\":null},{\"id\":\"https://openalex.org/A5007560986\",\"display_name\":\"T. Páleníček\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100953\",\"is_oa\":true}}", "topic_tags": "Animal Study", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313199409" }, { "id": 5017, "title": "Acute change in functional brain entropy following psilocybin administration in healthy volunteers", "normalized_title": "acute change in functional brain entropy following psilocybin administration in healthy volunteers", "authors": "Drummond E-Wen McCulloch, Anders Smærup Olsen, Dea Siggaard Stenbæk, Sophia Armand, M.K. Madsen, Gitte M. Knudsen, Patrick M. Fisher", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100701", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100701", "keywords": "Psilocybin, Medicine, Psychology, Hallucinogen, Pharmacology, Psychedelics and Drug Studies, Mental Health Research Topics, Mental Health and Psychiatry", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4313199337\",\"openalex_url\":\"https://openalex.org/W4313199337\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5064300685\",\"display_name\":\"Drummond E-Wen McCulloch\",\"orcid\":\"https://orcid.org/0000-0001-6360-5224\"},{\"id\":\"https://openalex.org/A5086988891\",\"display_name\":\"Anders Smærup Olsen\",\"orcid\":\"https://orcid.org/0000-0001-8589-1436\"},{\"id\":\"https://openalex.org/A5004791170\",\"display_name\":\"Dea Siggaard Stenbæk\",\"orcid\":\"https://orcid.org/0000-0002-5439-4637\"},{\"id\":\"https://openalex.org/A5086179765\",\"display_name\":\"Sophia Armand\",\"orcid\":\"https://orcid.org/0000-0001-6368-3329\"},{\"id\":\"https://openalex.org/A5113999896\",\"display_name\":\"M.K. Madsen\",\"orcid\":null},{\"id\":\"https://openalex.org/A5015895924\",\"display_name\":\"Gitte M. Knudsen\",\"orcid\":\"https://orcid.org/0000-0003-1508-6866\"},{\"id\":\"https://openalex.org/A5021085020\",\"display_name\":\"Patrick M. Fisher\",\"orcid\":\"https://orcid.org/0000-0002-8115-0611\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100701\",\"is_oa\":true}}", "topic_tags": "Pharmacology,Healthy Volunteers", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313199337" }, { "id": 5007, "title": "Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjects", "normalized_title": "comparison of subjective autonomic and endocrine effects of lsd and psilocybin in healthy subjects", "authors": "Friederike Holze, Laura Ley, F. Müller, V. Nimmy, Anne Eckert, Matthias E. Liechti", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100075", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100075", "keywords": "Psilocybin, Endocrine system, Hallucinogen, Psychology, Medicine, Neuroscience, Endocrinology, Pharmacology, Hormone, Psychedelics and Drug Studies, Paranormal Experiences and Beliefs, Religious Studies and Spiritual Practices", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4221097544\",\"openalex_url\":\"https://openalex.org/W4221097544\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5028081191\",\"display_name\":\"Friederike Holze\",\"orcid\":\"https://orcid.org/0000-0003-3143-1519\"},{\"id\":\"https://openalex.org/A5102828957\",\"display_name\":\"Laura Ley\",\"orcid\":\"https://orcid.org/0009-0003-9881-4693\"},{\"id\":\"https://openalex.org/A5102258902\",\"display_name\":\"F. Müller\",\"orcid\":null},{\"id\":\"https://openalex.org/A5003113646\",\"display_name\":\"V. Nimmy\",\"orcid\":null},{\"id\":\"https://openalex.org/A5052160307\",\"display_name\":\"Anne Eckert\",\"orcid\":\"https://orcid.org/0000-0002-9341-3669\"},{\"id\":\"https://openalex.org/A5071962736\",\"display_name\":\"Matthias E. Liechti\",\"orcid\":\"https://orcid.org/0000-0002-1765-9659\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100075\",\"is_oa\":true}}", "topic_tags": "Pharmacology,Spirituality", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4221097544" }, { "id": 5006, "title": "Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorder", "normalized_title": "investigating cue reactivity as biomarker for treatment success in psilocybin assisted therapy for alcohol use disorder", "authors": "Nathalie M. Rieser, Ladina P Gubser, C. Rossgoderer Da Silva, Franz X. Vollenweider, Marcus Herdener, Katrin H. Preller", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100102", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100102", "keywords": "Psilocybin, Cue reactivity, Biomarker, Alcohol use disorder, Reactivity (psychology), Psychology, Alcohol, Psychotherapist, Cocaine use, Psychiatry, Medicine, Hallucinogen, Addiction, Craving, Chemistry, Alternative medicine, Pathology, Biochemistry, Psychedelics and Drug Studies, Mental Health Research Topics, Digital Mental Health Interventions", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4220743600\",\"openalex_url\":\"https://openalex.org/W4220743600\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":0,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5050105328\",\"display_name\":\"Nathalie M. Rieser\",\"orcid\":\"https://orcid.org/0000-0002-5804-1409\"},{\"id\":\"https://openalex.org/A5055186073\",\"display_name\":\"Ladina P Gubser\",\"orcid\":null},{\"id\":\"https://openalex.org/A5015558705\",\"display_name\":\"C. Rossgoderer Da Silva\",\"orcid\":null},{\"id\":\"https://openalex.org/A5086283052\",\"display_name\":\"Franz X. Vollenweider\",\"orcid\":\"https://orcid.org/0000-0001-9053-6164\"},{\"id\":\"https://openalex.org/A5005591219\",\"display_name\":\"Marcus Herdener\",\"orcid\":\"https://orcid.org/0000-0001-5830-1971\"},{\"id\":\"https://openalex.org/A5040977207\",\"display_name\":\"Katrin H. Preller\",\"orcid\":\"https://orcid.org/0000-0003-0413-7672\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100102\",\"is_oa\":true}}", "topic_tags": "Addiction,Biomarkers", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4220743600" }, { "id": 5005, "title": "The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial", "normalized_title": "the efficacy of comp360 psilocybin therapy in treatment resistant depression exploratory results from a phase iib randomised controlled trial", "authors": "G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Allan H. Young, Sidney Zisook, E. Malievskaia", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100213", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100213", "keywords": "Psilocybin, Depression (economics), Psychotherapist, Psychology, Treatment-resistant depression, Randomized controlled trial, Psychiatry, Medicine, Clinical psychology, Internal medicine, Hallucinogen, Major depressive disorder, Cognition, Economics, Macroeconomics, Psychedelics and Drug Studies, Digital Mental Health Interventions, Mental Health Research Topics", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4313200620\",\"openalex_url\":\"https://openalex.org/W4313200620\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"compound:comp360\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":1,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5077798189\",\"display_name\":\"G. Goodwin\",\"orcid\":null},{\"id\":\"https://openalex.org/A5064457148\",\"display_name\":\"Scott T. Aaronson\",\"orcid\":\"https://orcid.org/0000-0001-7616-8801\"},{\"id\":\"https://openalex.org/A5056637382\",\"display_name\":\"Boadie W. Dunlop\",\"orcid\":\"https://orcid.org/0000-0002-4653-0483\"},{\"id\":\"https://openalex.org/A5080395573\",\"display_name\":\"D. Feifel\",\"orcid\":null},{\"id\":\"https://openalex.org/A5048687842\",\"display_name\":\"David J. Hellerstein\",\"orcid\":\"https://orcid.org/0000-0002-8031-4354\"},{\"id\":\"https://openalex.org/A5047032117\",\"display_name\":\"L. Marwood\",\"orcid\":null},{\"id\":\"https://openalex.org/A5016967968\",\"display_name\":\"S. Mistry\",\"orcid\":null},{\"id\":\"https://openalex.org/A5021140380\",\"display_name\":\"Metten Somers\",\"orcid\":\"https://orcid.org/0000-0002-9381-5596\"},{\"id\":\"https://openalex.org/A5012370983\",\"display_name\":\"S.C. Stansfield\",\"orcid\":null},{\"id\":\"https://openalex.org/A5043433258\",\"display_name\":\"J. Tsai\",\"orcid\":null},{\"id\":\"https://openalex.org/A5042134638\",\"display_name\":\"S. Williams\",\"orcid\":null},{\"id\":\"https://openalex.org/A5058414502\",\"display_name\":\"Allan H. Young\",\"orcid\":\"https://orcid.org/0000-0003-2291-6952\"},{\"id\":\"https://openalex.org/A5053651400\",\"display_name\":\"Sidney Zisook\",\"orcid\":\"https://orcid.org/0000-0003-3341-9185\"},{\"id\":\"https://openalex.org/A5012063316\",\"display_name\":\"E. Malievskaia\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100213\",\"is_oa\":true}}", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression", "study_type": "Randomized Controlled Trial", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313200620" }, { "id": 5002, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial", "normalized_title": "the safety and efficacy of comp360 psilocybin therapy in treatment resistant depression results from a phase iib randomised controlled trial", "authors": "G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Antony Young, Sidney Zisook, E. Malievskaia", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100511", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "keywords": "Psilocybin, Depression (economics), Treatment-resistant depression, Phase (matter), Medicine, Psychotherapist, Psychology, Psychiatry, Hallucinogen, Major depressive disorder, Cognition, Chemistry, Economics, Organic chemistry, Macroeconomics, Psychedelics and Drug Studies, Digital Mental Health Interventions, Psychotherapy Techniques and Applications", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4313199626\",\"openalex_url\":\"https://openalex.org/W4313199626\",\"openalex_relevance_score\":8,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\",\"compound:comp360\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":2,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5023164918\",\"display_name\":\"G.M. Goodwin\",\"orcid\":null},{\"id\":\"https://openalex.org/A5064457148\",\"display_name\":\"Scott T. Aaronson\",\"orcid\":\"https://orcid.org/0000-0001-7616-8801\"},{\"id\":\"https://openalex.org/A5056637382\",\"display_name\":\"Boadie W. Dunlop\",\"orcid\":\"https://orcid.org/0000-0002-4653-0483\"},{\"id\":\"https://openalex.org/A5000063591\",\"display_name\":\"David Feifel\",\"orcid\":\"https://orcid.org/0000-0002-8185-0220\"},{\"id\":\"https://openalex.org/A5048687842\",\"display_name\":\"David J. Hellerstein\",\"orcid\":\"https://orcid.org/0000-0002-8031-4354\"},{\"id\":\"https://openalex.org/A5039824360\",\"display_name\":\"N. Hewitt\",\"orcid\":null},{\"id\":\"https://openalex.org/A5047032117\",\"display_name\":\"L. Marwood\",\"orcid\":null},{\"id\":\"https://openalex.org/A5016967968\",\"display_name\":\"S. Mistry\",\"orcid\":null},{\"id\":\"https://openalex.org/A5021140380\",\"display_name\":\"Metten Somers\",\"orcid\":\"https://orcid.org/0000-0002-9381-5596\"},{\"id\":\"https://openalex.org/A5012370983\",\"display_name\":\"S.C. Stansfield\",\"orcid\":null},{\"id\":\"https://openalex.org/A5043433258\",\"display_name\":\"J. Tsai\",\"orcid\":null},{\"id\":\"https://openalex.org/A5042134638\",\"display_name\":\"S. Williams\",\"orcid\":null},{\"id\":\"https://openalex.org/A5087076735\",\"display_name\":\"Antony Young\",\"orcid\":null},{\"id\":\"https://openalex.org/A5053651400\",\"display_name\":\"Sidney Zisook\",\"orcid\":\"https://orcid.org/0000-0003-3341-9185\"},{\"id\":\"https://openalex.org/A5012063316\",\"display_name\":\"E. Malievskaia\",\"orcid\":null}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100511\",\"is_oa\":true}}", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313199626" }, { "id": 5001, "title": "Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjects", "normalized_title": "pharmacokinetics and pharmacokinetic pharmacodynamic relationship of oral psilocybin administration in healthy subjects", "authors": "Friederike Holze, A. Becker, Karolina E. Kolaczynska, Urs Duthaler, Matthias E. Liechti", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100410", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100410", "keywords": "Psilocybin, Pharmacokinetics, Pharmacology, Pharmacodynamics, Medicine, Oral administration, Hallucinogen, Psychedelics and Drug Studies, Complementary and Alternative Medicine Studies, Mental Health and Psychiatry", "substance_tags": "psilocybin", "source_name": "OpenAlex", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "raw_json": "{\"openalex_id\":\"https://openalex.org/W4313200314\",\"openalex_url\":\"https://openalex.org/W4313200314\",\"openalex_relevance_score\":6,\"openalex_relevance_reasons\":[\"title:psilocybin\",\"metadata:psilocybin\"],\"openalex_type\":\"article\",\"openalex_work_type\":null,\"cited_by_count\":3,\"referenced_works\":[],\"authorships\":[{\"id\":\"https://openalex.org/A5028081191\",\"display_name\":\"Friederike Holze\",\"orcid\":\"https://orcid.org/0000-0003-3143-1519\"},{\"id\":\"https://openalex.org/A5012996786\",\"display_name\":\"A. Becker\",\"orcid\":\"https://orcid.org/0000-0001-5308-7945\"},{\"id\":\"https://openalex.org/A5055068028\",\"display_name\":\"Karolina E. Kolaczynska\",\"orcid\":\"https://orcid.org/0000-0003-1714-0758\"},{\"id\":\"https://openalex.org/A5024133720\",\"display_name\":\"Urs Duthaler\",\"orcid\":\"https://orcid.org/0000-0002-7811-3932\"},{\"id\":\"https://openalex.org/A5071962736\",\"display_name\":\"Matthias E. Liechti\",\"orcid\":\"https://orcid.org/0000-0002-1765-9659\"}],\"primary_location\":{\"source_id\":\"https://openalex.org/S4210236820\",\"source_display_name\":\"Neuroscience Applied\",\"landing_page_url\":\"https://doi.org/10.1016/j.nsa.2022.100410\",\"is_oa\":true}}", "topic_tags": "Pharmacology", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313200314" }, { "id": 2020, "title": "Rats hallucinate in a similar manner to humans after psilocin", "normalized_title": "rats hallucinate in a similar manner to humans after psilocin", "authors": "Vejmola Č., Syrová K., Šíchová K., Vlastimil K., Klučková T., Kelemen E., Páleníček T.", "abstract": "", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100950", "pubmed_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2022.100950", "keywords": "", "substance_tags": "psilocin", "source_name": "Crossref", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-01 11:21:33", "raw_json": "{\"doi\":\"10.1016/j.nsa.2022.100950\",\"reference_dois\":[],\"reference_count\":0}", "topic_tags": "General", "study_type": "Other", "hidden": 0, "false_positive": 0, "curation_notes": null, "merged_into_id": null, "curation_locked": 0, "publication_status": "published", "openalex_id": "https://openalex.org/W4313201263" } ] }